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ABSTRACT 
 
Progesterone Regulation of Endometrial Gene Expression  
in the Early Pregnant Ovine Uterus.  (August 2011) 
Megan A. Minten, B.S., North Dakota State University 
Co-Chairs of Advisory Committee:  Dr. Thomas E. Spencer 
                 Dr. Fuller W. Bazer 
 
 
Establishment of pregnancy in ruminants requires blastocyst development to form an 
elongated filamentous conceptus that produces interferon tau (IFNT), the pregnancy recognition 
signal, and initiate implantation.  Blastocyst growth and development is dependent upon 
secretions from the uterine endometrium.  An early increase in post-ovulatory circulating levels 
of progesterone (P4) stimulates blastocyst growth and conceptus elongation in ruminants.  
Microarray analysis was used to identify candidate P4-regulated genes and regulatory networks 
in the endometrium that govern peri-implantation blastocyst/conceptus growth and development. 
The first study was conducted to validate effects of P4 and/or pregnancy on expression 
of candidate genes identified by microarray analysis.  The genes included: ANGPTL3, CHGA, 
CLEC4E, CXCL14, EFNA1, EFNB1, FABP3, IFNG, IL6, LGALS3, PTH, RBP4, SLIT2, SLIT3, 
and VWF.  Early P4 treatment up-regulated CXCL14 gene expression in Day 9 ovine 
endometrium compared to control endometrium, and FABP3, IFNG, IL6 and LGALS3 in Day 12 
early P4-treated ovine endometrium.  Expression of ANGPTL3, CHGA, CXCL14, EFNA1, 
EFNB1, LGALS3 and RBP4 was affected by day of pregnancy.  Treatment of ewes with 
P4+RU486 (P4 receptor antagonist) reduced expression of ANGPTL3, CHGA, EFNA1, EFNB1, 
FABP3, IFNG, IL6, LGALS3, RBP4, and SLIT2, SLIT3 and VWF in comparison to Day 12 P4-
treated endometrium.    
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The second study evaluated expression of genes identified by microarray analysis in 
endometrium from pregnant and cyclic ewes.  Genes evaluated included those from the first 
study.  ANGPTL3, CHGA, CXCL14, EFNA1, EFNB1, IFNG, LGALS3, PTH, RBP4, SLIT2, 
SLIT3 and VWF were affected by day, status and/or their interaction between Days 10 and 16.  
Of note, FABP3 increased 21-fold between Days 14 to 18 of pregnancy, and IL6 increased 37-
fold between Days 14 to 20 of pregnancy.  In situ hybridization analysis detected FABP3 mRNA 
in both luminal and superficial glandular epithelia of pregnant ewes and trophectoderm, whereas 
IL6 mRNA was detected in immune cells within uterine luminal epithelium and glandular 
epithelium and trophectoderm. 
Collectively, these results identify candidate genes encoding for biologically active 
molecules that regulate growth and development of the ovine conceptus during the peri-
implantation period of pregnancy.   
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CHAPTER I 
INTRODUCTION 
 
Successful establishment of pregnancy in ruminants involves complex communication 
between the conceptus (embryo and associated extraembryonic membranes) and mother.  The 
pregnancy recognition signal from the ovine conceptus and other ruminant species is interferon 
tau (IFNT), a Type 1 IFN.  Interferon tau exerts effects on the uterine epithelia to maintain a 
functional corpus luteum (CL) by silencing expression of estrogen receptor alpha (ESR1) and 
oxytocin receptor (OXTR) to prevent oxytocin-induced pulsatile release of luteolytic 
prostaglandin F2α (PGF) from the endometrium that causes functional and structural regression 
of the CL.  The CL produces the hormone progesterone (P4), the required hormone of pregnancy 
that is critical to establishment of a maternal uterine environment conducive to conceptus 
growth, implantation, placentation and fetal development.   
Progesterone and/or IFNT act on the endometrium to increase production of secretions 
that are termed histotroph and are vital for conceptus growth in ruminants.  Histotroph is a 
complex mixture of enzymes, growth factors, cytokines, hormones, transport proteins, serum 
proteins, adhesion proteins, protease inhibitors, amino acids and other substances (Spencer et al. 
2004b; Bazer et al. 2009).  Evidence demonstrates that endometrial glands are necessary for 
blastocyst development into an elongated conceptus that can establish and maintain a pregnancy 
(Bartol et al. 1995; Gray et al. 2000a; Gray et al. 2001b).  Furthermore, asynchronous embryo 
transfer studies demonstrated the temporal necessity of maternal hormonal influences on 
endometrial functions to produce histotroph for survival and growth of the conceptus during the 
protracted peri-implantation period of pregnancy in ruminants (Lawson et al. 1983; Pope 1988). 
_______________ 
This thesis follows the style of Reproduction, Fertility and Development. 
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Progesterone receptors (PGR) are down-regulated in response to continuous P4 exposure 
in uterine luminal (LE) and glandular epithelia (GE) by Day 11 and 13, respectively (Wathes and 
Hamon 1993; Spencer et al. 1995b).  Down-regulation of PGR allows for a rapid increase in 
expression of ESR1 after Day 13 of the estrous cycle.  The increase in ESR1 expression precedes 
the increase of OXTR expression (Flint et al. 1986; Spencer et al. 1995a).  Oxytocin (OXT) 
released in a pulsatile manner from the posterior pituitary and CL binds OXTR on uterine LE 
and superficial glandular epithelium (sGE) to initiate the secretion of luteolytic pulses of PGF 
(McCracken 1980; Flint et al. 1986).  However IFNT, secreted by mononuclear trophectoderm 
cells of the elongating conceptus, acts in a paracrine manner to exert antiluteolytic effects by 
suppressing up-regulation of ESR1, thus preventing increases in OXTR gene expression in LE 
and sGE to abrogate development of the uterine luteolytic mechanism (Lamming et al. 1995; 
Spencer et al. 1995a).  IFNT suppresses ESR1 transcription through a pathway involving 
interferon regulatory factor two (IRF2), a transcriptional repressor in LE and sGE (Fleming et al. 
2001).  Thereby IFNT inhibits transcription of ESR1 preceding transcription of OXTR 
consequently preventing OXT-induced release of luteolytic pulses of PGF.  Thus, a functional 
CL is maintained to secrete progesterone throughout pregnancy.  Ovarian P4 induces and 
conceptus IFNT stimulates a number of genes (Spencer et al. 2008; Bazer et al. 2010).  
Particularly, IFNT stimulates an increase in enzymes involved in prostaglandin (PG) synthesis 
and secretion.  Recently, it was found that prostaglandin G/H synthase and cyclooxygenase 2 
(PTGS2)-derived PGs mediate, in part, effects of P4 and IFNT on expression of endometrial 
genes regulating growth and development of the blastocyst and elongation of the conceptus 
(Dorniak et al. 2011). 
Research with cattle and sheep found that the post-ovulatory rise in P4 after mating is 
correlated with conceptus growth and development (Garrett et al. 1988; Mann et al. 2006; 
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Satterfield et al. 2006).  Ovarian P4 stimulates conceptus development through secretions from 
the endometrium (Bazer et al. 2008).  In sheep, administration of exogenous P4 during metestrus 
accelerated growth of hatched blastocysts as evidenced by the presence of filamentous 
conceptuses on Day 12 in P4-treated ewes while only spherical to tubular blastocysts were 
recovered from uteri of control ewes on Day 12 of pregnancy (Satterfield et al. 2006).  
Additionally, IFNT in uterine flushings from Day 12 uteri was markedly higher in early P4-
treated ewes.   
Gene profiling of the endometrial transcriptome in pregnant ewes treated with 
exogenous P4 identified novel candidate genes and regulatory pathways governing 
preimplantation growth and development of the conceptus.  The Database for Annotation, 
Visualization, and Integrated Discovery (DAVID) was used to identify functional groups of 
genes and biological processes in the endometrium associated with the growth and development 
of preimplantation blastocysts (Satterfield et al. 2009).  Selected genes identified were associated 
with regulation of cell migration (ANGPTL3), extracellular space (CHGA), integral to membrane 
(CLEC4E), chemokine activity (CXCL14), protein binding and cellular differentiation  (EFNA1 
and EFNB1), fatty acid binding (FABP3), interferon gamma precursor (IFNG), humoral immune 
response (IL6), plasma membrane (LGALS3), hormone activity (PTH), extracellular space and 
retinol binding (RBP4), extracellular space and receptor binding (SLIT2 and SLIT3), and growth 
factor activity (VWF) (Satterfield et al. 2009). 
Collectively, results of these studies indicate the role of P4 in inducing expression of 
molecules essential for the culmination of successful establishment of pregnancy.  Knowledge of 
the endometrial gene profile during early pregnancy provides insight in gene pathways involved 
in blastocyst growth and conceptus development (Satterfield et al. 2009).  Therefore, studies 
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were conducted to validate candidate P4-regulated genes and determine effects of the estrous 
cycle and pregnancy on expression of candidate genes in the endometrium. 
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CHAPTER II 
LITERATURE REVIEW 
 
Embryonic Development  
 Embryonic development begins with syngamy, the fusion of the male and female 
pronuclei resulting in a one cell embryo or zygote.  The zygote develops by mitotic divisions, 
also referred to as cleavage divisions.  Cleavage occurs within the zona pellucida, an 
extracellular matrix of glycoproteins.  The cells comprising the embryo are referred to as 
blastomeres.  Cytoplasmic mass does not increase during cleavage; therefore, there is an increase 
in the number of blastomeres with a fixed volume of cytoplasm.  Around the 16- to 32-cell stage, 
blastomeres flatten on one another to form a solid, rounded ball of cells referred to as a morula.  
The surface microvilli of blastomeres also become asymmetrically polarized and undergo 
polarization.  The combination of flattening and polarization of blastomeres is referred to as 
compaction.  The outer blastomeres become more compacted than the inner cells.  The 
peripheral cells form the cuboidal trophectoderm, which is covered by dense microvilli and 
allows for the accumulation of fluid by active ion transport to form a central cavity referred to as 
the blastocoele during cavitation.  Gap junctions formed by the inner cells allows for 
communication between blastomeres and leads to the formation of the inner cell mass or 
embryonic disc.  The blastocyst stage is achieved once an embryo has a recognizable 
blastocoele, inner cell mass and trophectoderm.  The inner cell mass gives rise to the embryo 
proper that develops into the three germ layers (endoderm, mesoderm and ectoderm).  The 
trophectoderm cells become highly attenuated and organized into a simple squamous epithelium 
which serves to translocate nutrients from the maternal environment into the blastocoele, and 
will later give rise to the chorion of the placenta (Zernicka-Goetz 2005). 
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Figure 2.1.  Early pregnancy events in sheep.  This schematic describes relationships between 
development of the embryo and conceptus with respect to hormonal status and position within 
the maternal uterine environment.  Embryos enter the uterus on Days 4-5 post-fertilization (Day 
0), reach the blastocyst stage on Day 6 and hatch from the zona pellucida by Day 9.  The 
blastocyst transitions from a spherical to a tubular form by Day 11.  Elongation to a filamentous 
conceptus occurs between Days 12 and 16 during which time the conceptus is apposed to the 
uterine LE and begins adhesion around Day 16.  The conceptus will occupy the entire ipsilateral 
uterine horn and elongate into the contralateral uterine horn.  The hormone profile of the 
maternal environment during early pregnancy is predominantly progesterone.  Copied from 
(Spencer et al. 2007) and originally drawn by Dr. Greg A. Johnson, Texas A&M University. 
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Conceptus Development and Implantation in Ruminants 
Fertilization of the oӧcyte by sperm occurs within the ampullary-isthmic junction of the 
oviduct in ruminants (sheep, goat and cattle).  Morula stage embryos enter the uterus on Days 4-
5.  By Day 6, blastocysts contain a blastocoele and inner cell mass surrounded by a monolayer of 
trophectoderm.  The zona pellucida remains intact on Day 8 with numerous microvilli on the 
external surface of flattened trophectoderm and junctional complexes formed within the basal 
and lateral plasma membrane (Wintenberger-Torres and Flechon 1974; Spencer et al. 2004a).  
Endoderm cells migrate below the trophectoderm to form the extra-embryonic endoderm that 
lines the blastocoele.  This ectoderm-endoderm double barrier separates the blastocoele from the 
external uterine milieu (Flechon et al. 2007).  The endoderm differentiates into the visceral 
endoderm first and then the parietal endoderm.  The endoderm reaches the equator of the 
blastocyst by Day 9 and the abembryonic pole by Day 10 (Wintenberger-Torres and Flechon 
1974). 
A diversity of implantation and placentation strategies exist among species however 
homology exists in the primary stages of establishing contact between the maternal and 
conceptus tissues (Spencer et al. 2004a).  A comparative implantation scheme proposed by 
Guillomot and colleagues (Guillomot et al. 1981; Chavatte-Palmer and Guillomot 2007) has 
defined implantation as: 1) shedding of the zona pellucida; 2) pre-contact and blastocyst 
orientation; 3) apposition; 4) adhesion; and 5) endometrial invasion (however, endometrial 
invasion by the blastocyst does not occur in uteri of ruminants).  The events of conceptus 
implantation are summarized in Figure 2.1.  Expansion of the blastocoele and uterine and/or 
embryonic proteases results in the hatching of the blastocyst (approximately 300 cells) from the 
zona pellucida by Day 9 in sheep and Day 10 in cattle (Bindon 1969; Bindon 1971; Guillomot et 
al. 1988; Hafez 1993; Chavatte-Palmer and Guillomot 2007).  After hatching and prior to 
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implantation, the ruminant blastocyst undergoes a rapid expansion that results in morphological 
changes and lengthening (Guillomot et al. 1988).  By Day 10, the blastocyst measures 400-900 
µm in diameter and contains approximately 3000 cells (Spencer et al. 2004a).  In contrast to 
implantation of rodents, primates and humans, ruminants have a protracted peri-implantation 
period.   
During the phase of pre-contact and orientation, the blastocyst transitions from spherical 
to tubular to filamentous forms.  Trophectoderm elongation in sheep and cattle is initiated 
around Day 11 and Day 12, respectively (Guillomot et al. 2004; Blomberg et al. 2008).  The 
parietal endoderm transitions to a multinucleated syncytium as it spreads from the embryonic 
disc to the elongating tips of the conceptus.  Nuclear division, without cytokinesis, orients cells 
parallel to the long axis of the conceptus.  The visceral endoderm retains features of a typical 
epithelium (Flechon et al. 2007).  The trophectoderm transitions from flattened to cuboidal 
epithelia with high secretory activity evidenced by abundant endoplasmic reticulum 
(Wintenberger-Torres and Flechon 1974).  By Day 13 in the sheep conceptus, the embryonic 
disc is raised above the elongated trophectoderm and the yolk sac is formed as an evagination of 
the foregut (Flechon et al. 1986; Wales and Cuneo 1989; Guillomot 1995).  At Day 14, the 
approximately 10 cm filamentous conceptus appears to have a primitive streak and somites 
appear in the embryo soon thereafter (Wintenberger-Torres and Flechon 1974).  The 
trophectoderm length increases 90-fold from Day 13 to 19 to resemble a long filament that will 
elongate from the uterine horn ipsilateral to the CL into the contralateral uterine horn by Day 17 
(Rowson and Moor 1966; Wales and Cuneo 1989; Spencer et al. 2004a).  During elongation, the 
conceptus trophectoderm secretes IFNT.  The rate and timing of elongation of the trophectoderm 
is dependent upon the uterine environment.  Blastocysts and trophoblastic vesicles do not 
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elongate in vitro unless transferred to the uterus because they require endometrial secretions and 
the uterine LE to elongate (Lawson et al. 1983; Flechon et al. 1986; Spencer et al. 2004a).   
Apposition is defined as the first contact between the apical membranes of the 
trophectoderm and uterine LE (Spencer et al. 2004a).  During this stage, the columnar 
trophectoderm is closely pressed against the endometrial cell apex which imprints on the 
trophectoderm surface (Guillomot et al. 1981; Wooding 1984; Chavatte-Palmer and Guillomot 
2007).  First cell contact begins around the embryonic region and spreads towards the tips of the 
elongating conceptus.  Additionally, the trophectoderm attaches mainly to the caruncular 
(aglandular endometrium) LE and to the intercaruncular LE/sGE to a lesser extent (Chavatte-
Palmer and Guillomot 2007).  In areas of microvilli deficiency in both LE and trophectoderm, 
membranes are discontinuously apposed (Guillomot et al. 1981).  Specialized structures are 
formed in the sheep and cattle trophectoderm (interestingly, not in goat trophectoderm) termed 
papillae, which are finger-like villi that extend into superficial ducts of uterine glands between 
Days 15 to 18 of pregnancy.  The papillae may serve as anchoring pegs, especially in the 
papillae dense embryonic disc region where immobilization would be advantageous in 
maintaining a close contact with the nutrient supply (Wooding et al. 1982). 
Adhesion begins around Day 16; however, it is loose and embryonic membranes can be 
dislodged by flushing the uterine lumen with saline (Boshier 1969) .  Adhesion is the result of 
interlocking of the uterine microvilli and trophectoderm cytoplasmic projections (Guillomot et 
al. 1981).  By Day 22, adhesion appears to be complete along the length of the conceptus in both 
caruncular and intercaruncular regions.  The external surface of the uterine LE and 
trophectoderm is composed of a glycocalyx, which is a glycoprotein coat.  The biochemistry of 
the glycocalyx is modified by the hormonal status of the maternal environment.  During the 
luteal phase of continuous P4 exposure, PGR expression is down-regulated in concert with anti-
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adhesive factors (Dharmaraj et al. 2010).  MUC1 is particularly abundant on the microvilli and 
cilia that extend from the apical cell surface of the endometrial LE.  MUC1 is thought to 
sterically interfere with adhesion molecules between the trophectoderm and uterine LE due to 
extensive glycosylation and extended extracellular structure (Burghardt et al. 2002).  Down-
regulation of MUC1 between Days 9 and 17 of pregnancy allows for the implantation cascade to 
occur in sheep (Johnson et al. 2001a).  GLYCAM1 (glycosylation dependent cell adhesion 
molecule 1) (Spencer et al. 1999; Muniz et al. 2006), LGALS15 (lectin, galactoside-binding, 
soluble 15) (Lewis et al. 2007; Farmer et al. 2008) , SPP1 (secreted phosphoprotein 1 or 
osteopontin) (Johnson et al. 2003a; Johnson et al. 2003b; Dunlap et al. 2008), IGFBP1 (insulin-
like growth factor binding protein-1) (Simmons et al. 2009), and integrins (Johnson et al. 2001a; 
Burghardt et al. 2002; Burghardt et al. 2009) function as bridging ligands in establishing 
attachment between uterine LE and trophectoderm (Bazer et al. 2010). 
Mononucleate trophectoderm cells differentiate into giant binucleate cells (BNC) by 
nuclear division without cytokinesis resulting in polyploidy (Wooding 1984).  BNC cells migrate 
in between mononuclear cells and likely fuse with individual LE cells to form multinucleated 
syncytial plaques (Wooding 1984; Chavatte-Palmer and Guillomot 2007; Spencer et al. 2008).  
Continued migration and presumably fusion enlarge the syncytium; however, these plaques 
appear to be limited to 20-25 nuclei in sheep.  Syncytial plaques are linked by tight junctions and 
localize to caruncular regions to aid in formation of the placentome (Wooding 1984; Spencer et 
al. 2004a).  Formation of syncytial plaques starts initially in caruncular regions adjacent to the 
embryo and extends toward the tips of the horns.  Although BNC are inherently invasive, they do 
not cross the basal lamina of the LE (Spencer et al. 2004a).  BNC formation has two main 
functions: 1) to form placentomes, and 2) to produce and secrete protein and steroid hormones 
(Wooding 1992).  Wooding used phosphotungstic acid (PTA) staining to demonstrate granules 
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from BNC streaming down to the maternal interface suggesting exocytosis (Wooding 1984).   
Exocytosis of steroid and protein hormones includes pregnancy associated glycoproteins 
(PAGS), P4 and placental lactogen (chorionic somatomammotropin hormone 1, CSH1) which 
act on endometrial glands to stimulate their development and secretion of proteins (Wooding 
1992; Spencer et al. 2007).  BNC undergo migration and fusion throughout most of pregnancy.  
In sheep, more than 95% of the placentomal and interplacentomal regions of the fetomaternal 
interface is formed by hybrid syncytial plaques in the second half of pregnancy (Wooding 1992).  
The transformation of mononuclear trophectoderm into syncytial tissue could also contribute to 
the protection of the conceptus allograft from the maternal immune system (Chavatte-Palmer and 
Guillomot 2007).   
 
Structure of Ruminant Fetomaternal Interface 
The fetomaternal interface of ruminants is of three types between Days 18 and 24 of 
pregnancy; 1) fetomaternal hybrid tissue of multinucleated syncytial plaques; 2) an interlocking 
microvillar junction between the trophectoderm and mononuclear uterine epithelium; and 3) flat 
apposition of trophectoderm to uterine LE (Wooding 1984).  Syncytial plaques develop in 
caruncular regions, which develop into placentomes that are specialized structures comprised of 
fetal cotyledons and maternal caruncles.  The placentome structure is formed by the folding of 
the caruncular region thereby forming deep caruncular crypts which are penetrated by long, 
profusely branched cotyledonary villi (Igwebuike 2009).  Thus the ruminant placenta is 
synepitheliochorial, being neither entirely syndesmochorial (without endometrial LE), nor 
completely epitheliochorial (with two apposed epithelia).  An additional unique feature of the 
ruminant placenta (as well as that for pigs and horses) are interplacentomal areolae which 
develop as specialized areas for absorption of histotroph from the mouth of endometrial glands 
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(Spencer and Bazer 2004b).  The developing conceptus, and later in gestation, the fetus, will 
continue to utilize histotrophic nutrition.  Intercaruncular endometrial glands grow substantially 
in length and width throughout pregnancy (Wimsatt 1950).  By Day 40, there is maximum 
juxtaposition of the maternal and fetal microvasculature (Cross et al. 2003).  Placentomes 
provide a critical source of hematotrophic nutrition for the fetus during gestation due to the close 
proximity of the vasculature for the exchange of gases and micronutrients (Reynolds et al. 2010).  
The sheep placenta has approximately 90 to 100 placentomes evenly distributed throughout the 
fetomaternal interface (Hafez 1993).  Placentation in ewes is essentially complete by 
approximately Days 50 to 60 (Guillomot 1995). 
 
Effects of Interferon Tau and Prostaglandins  
 Interferon tau (IFNT), a Type I Interferon, shares high structural homology with 
interferons alpha (IFNA), beta (IFNB), delta (IFND) and omega (IFNW1) (Bazer et al. 2009).  
IFNT is unique to ruminants and has antiviral, antitumor, antiproliferative, immunomodulatory 
and therapeutic activities similar to other Type I IFNs (Pontzer et al. 1990; Bazer and Johnson 
1991; Soos et al. 1995; Chon and Bixler 2010).  The biological functions of IFNT in ruminants 
are in pregnancy recognition signaling to abrogate development of the luteolytic mechanism and 
as an inducer/stimulator of expression of genes critical for implantation and conceptus 
development.   
 Prostaglandins possess vasoactive, mitogenic and differentiating properties, and are 
implicated in various female reproductive functions (Wang and Dey 2005).  Prostaglandins are 
generated from arachidonic acid by phospholipase A2 (PLA2) and PTGS2 enzymes into an 
unstable endoperoxide intermediate, PGH2.  PGH2 is metabolized to five structurally active 
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related PGs including PGE2, PGD2, PGF, PGI2 and thromboxane A2 via cell specific isomerase 
and specific PG synthases.  
 Ruminants are polyestrous, spontaneous ovulators.  Sheep and cattle have estrous 
lengths of 17-18 and 21 days, respectively.  Following ovulation and during metestrus, 1-4 days 
after onset of estrus, theca and granulosa cells of the ovulatory follicle undergo luteinization 
under the influence of LH, resulting in a CL that secretes P4 with Day 4 of the estrous cycle and 
pregnancy marking the initial day of diestrus.  The CL will reach maximum size on Day 7 and 
maintain high P4 secretion until approximately Day 14 of the estrous cycle.  Progesterone 
maintains the myometrium in a quiescent state, promotes an endometrial environment conducive 
for pregnancy, and suppresses dominant follicles from ovulating during diestrus (Bazer et al. 
1998).  In addition to P4 preparing the uterus for pregnancy, P4 stimulates phospholipid stores 
for arachidonic acid availability in the endometrium, and IFNT increases activity of PTGS2 for 
synthesis of arachidonic acid to prostaglandins (Dorniak et al. 2011).    
Progesterone receptors (PGR) in ovine uterine LE and GE are down-regulated under 
continuous P4 exposure on Days 11 and 13, respectively (Wathes and Hamon 1993; Spencer et 
al. 1995b).  Down-regulation of P4 allows for a rapid increase in expression of ESR1 in uterine 
epithelia after Day 13 and then estradiol from ovarian follicles stimulates OXTR expression 
(Flint et al. 1986; Spencer et al. 1995a).  Oxytocin from the posterior pituitary and CL, binds 
OXTR on the uterine LE and sGE to stimulate pulsatile release of luteolytic PGF (McCracken et 
al. 1984; Hixon and Flint 1987).  PGF released from uterine LE and sGE occurs as a series of 
episodic surges lasting approximately one hour with about five pulses in 25 hours (Thorburn et 
al. 1973; Baird et al. 1976; McCracken et al. 1984).  Sub-luteolytic pulses of PGF occur on Days 
13 and 14 in both cyclic and pregnant ewes, but luteolytic pulses of PGF occur on Days 15 and 
16 in cyclic ewes following an increase in circulating concentrations of estradiol (McCracken et 
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al. 1984; Bazer and Johnson 1991).  Uterine PGF is released into the utero-ovarian vein and 
transferred locally to the ovarian artery via a counter-current exchange in the vascular utero-
ovarian plexus resulting in delivery of high PGF concentrations to the CL (Heap et al. 1985; 
McCracken et al. 1999).  Luteolysis by PGF is caused by decreased luteal blood flow, 
uncoupling of LH receptors from adenyl cyclase, activation of phospholipase C that stimulates 
protein kinase C to modify posttranslational processes of steroidogenesis and cholesterol 
availability, apoptosis, and infiltration of immune cells to the CL during serum decline of P4.  
The decreased secretion of P4 is the result of decreased luteal blood flow of nutrients and 
steroidogenic substrates, and decreased steroidogenic capacity of the luteal cells.  Following 
PGF release, mRNA steroid conversion enzymes, cholesterol side chain cleavage enzyme 
complex and 3β-hydroxysteroid dehydrogenase, decline resulting in diminishing P4 levels 
followed by luteal cell loss (Niswender et al. 2000). 
IFNT is synthesized and secreted by the mononuclear trophectoderm of the elongating 
conceptus between Days 10 and 21 of pregnancy with highest production on Days 12 to 16 of 
pregnancy in sheep (Roberts et al. 1999).  IFNT acts in a paracrine manner on the endometrium 
to abrogate the luteolytic mechanism.  The antiluteolysin acts on the endometrium to suppress 
ESR1 transcription through the gene signaling pathway involving IRF2, a transcriptional 
repressor (Lamming et al. 1995; Spencer et al. 1995a; Fleming et al. 2001).  IRF2 is specifically 
expressed in uterine LE/sGE beginning on Day 10 of pregnancy.  IRF2 may mediate the effects 
of IFNT to silence ESR1 transcription following the PGR loss from uterine epithelia; therefore, 
actions of estradiol from ovarian follicles are unable to induce OXTR gene expression resulting 
in the development of the uterine luteolytic cascade.  Consequently, a functional CL secretes P4 
to maintain pregnancy.  
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IFNT either induces or stimulates P4-induced and IFNT stimulated genes (ISG) in 
uterine LE/sGE that are important for uterine receptivity to implantation and conceptus 
development (Bazer et al. 2009).  Interferon tau also stimulates expression of classical ISGs in 
extrauterine tissues and cells in the ewe (Yankey et al. 2001; Oliveira et al. 2008; Bazer et al. 
2009).  Type I IFNs induce cell signaling via the Janus-activated kinases (JAKs) and tyrosine 
kinase 2 (TYK2) pathways upon binding the heterodimer receptor complex (Darnell et al. 1994; 
Platanias 2005).  Not all cell types of the endometrium express ISGs.  IRF2, a transcriptional 
repressor, prevents the induction of ISG expression in ovine LE and sGE (Choi et al. 2001).  
Interestingly, nonclassical ISGs are expressed in the ovine uterine LE/sGE and are likely up-
regulated via a nonclassical signaling pathway that does not involve STAT1, STAT2 and 
IRF9/ISGF3G (Spencer and Bazer 2002).   
 IFNT abrogates luteolysis by inhibiting up-regulation of OXTR but does not inhibit PGF 
production.  Rather, IFNT up-regulates activity of PTGS2, the rate limiting enzyme of PG in the 
endometrium (Dorniak et al. 2011).   Additionally, ovine conceptuses have been shown to 
release PTGS2 metabolites (Marcus 1981; Lewis and Waterman 1985).  Changes in PTGS2 
abundance is coincident with 11-beta-hydroxysteroid dehydrogenase (HSD11B1), an enzyme 
induced by P4 and stimulated by IFNT and PGs (Simmons et al. 2009; Dorniak et al. 2011).  
HSD11B1 modulates the actions of glucocorticoids by generating active cortisol from inactive 
cortisone and has a positive feedback stimulation of cortisol, PGs and proinflammatory 
cytokines (Michael et al. 2003).  Glucocorticoids have beneficial effects that promote pregnancy, 
including stimulation of secretion of chorionic gonadotropin, suppression of uterine natural killer 
cells and promotion of trophoblast growth/invasion.  However, exogenous glucocorticoids have 
potential negative aspects that might compromise pregnancy by inhibiting cytokine-
prostaglandin signaling, restriction of trophoblast during implantation, induction of apoptosis 
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and inhibition of embryonic and placental growth (Michael and Papageorghiou 2008).  PTGS2-
derived PGs mediate effects of P4 to induce and IFNT to stimulate several epithelial genes 
(CST3, GRP, HSD11B1, LGALS15, and IGFBP1) that regulate conceptus elongation and 
implantation in the ovine uterus (Dorniak et al. 2011).   
 
Effects of Progesterone 
 Progesterone is a critical component of reproductive processes encompassing ovarian 
dynamics, sexual behavior, pregnancy and lactation (Hammes and Levin 2007; Gellersen et al. 
2009).  More specifically to the uterus, P4 regulates gland morphogenesis, gland function, cell 
adhesion, implantation of the conceptus and maintenance of pregnancy (Rexroad 1984; Spencer 
and Bazer 2002; Spencer et al. 2004b; Spencer et al. 2007).  Progesterone is a steroid hormone 
secreted by the CL, placenta and adrenal gland in sheep.  Following ovulation, theca and 
granulosa cells undergo luteinization in response to LH, differentiating into small and large 
luteal cells, respectively (Smith et al. 1994).  The ovulatory follicle will transition to a corpus 
hemorrhagicum (CH) temporarily, and then into the CL.  The CL begins secreting P4 into the 
circulation by approximately Day 4, reach maximal size on Day 7 and maintain secretion if 
uninterrupted by luteolytic activity (Bazer et al. 1998).  Progesterone is also secreted by the 
sheep placenta in sufficient quantities by Days 50 to 70 to maintain pregnancy and a second 
phase of increase between Days 90 to 120 of pregnancy (Ricketts and Flint 1980). 
The actions of P4 are mediated primarily through nuclear PGR which is a modular 
protein consisting of a centrally located, highly conserved DNA-binding domain (DBD), a 
carboxyl-terminal ligand-binding domain (LBD) and a variable amino-terminal domain 
(Conneely and Jericevic 2002; Gellersen et al. 2009).  There are two isoforms of PGR, A and B; 
PGRB differs from PGRA in that it is 164 nucleotides longer on the N-terminus.  The PGRA and 
 17 
PGRB isoforms are transcription factors that upon ligand binding recognize specific cis-acting 
hormone response elements usually located within the promoter region of genes to modulate 
gene expression.  However, modulation of gene expression requires cofactors (coactivators or 
corepressors) to induce or inhibit transcription of the gene upon which response element PGR-A 
and/or PGR-B is targeting (Gellersen et al. 2009). Thus PGRs ability to interact with DNA in 
response to ligand binding and recruitment of cofactors is the mechanism by which gene 
expression and protein synthesis occur in P4-dependent genes.  The P4 inducible gene network 
has been investigated to the greatest extent in mice and shown to encompass transcription and 
growth factors, homeobox genes and morphogens, peptide hormones, extracellular matrix and 
cell adhesion molecules, enzymes and protease inhibitors (Bagchi et al. 2003).  Mouse models 
for PGRA null isoform have severe abnormalities in ovarian and uterine function leading to 
infertility; whereas PGRB null mice have impaired mammary functions.  Thus PGRA is both 
necessary and sufficient to elicit P4-dependent reproductive responses necessary for female 
fertility, while PGRB is necessary for normal proliferative and differentiative responses of the 
mammary gland to P4 (Conneely and Jericevic 2002).  Non-genomic PGRs have been 
investigated in certain tissues; however, their particular modes of action in female reproductive 
tissues remains elusive (Gellersen et al. 2009). 
 All mammalian uteri contain endometrial glands that synthesize and secrete or transport 
a complex array of proteins and related substances termed histotroph (Spencer and Bazer 2004b).  
In sheep, endometrial gland morphogenesis occurs postnatally after withdrawal from a P4 
dominated prenatal environment at birth (Wiley et al. 1987; Gray et al. 2000a).  Therefore, 
inappropriate exposure of ewe lambs to a synthetic, nonmetabolizable progestin results in a 
uterine gland knock out (UGKO) phenotype (Bartol et al. 1988; Gray et al. 2000b).  The 
progestin epigenetically ablates development of uterine glands without disrupting development 
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of the myometrium and other Müllerian duct-derived female reproductive tract structures or the 
hypothalamic-pituitary-ovarian axis (Gray et al. 2001a).  UGKO ewes lack uterine GE and have 
reduced LE surface area.  The reduction of LE area results in insufficient OXTR to produce 
luteolytic PGF, thus UGKO ewes do not exhibit normal estrous cycles.  However when 
administered exogenous PGF, the CL regresses and the ewes exhibit normal estrus behavior 
(Gray et al. 2000a).  UGKO ewes are infertile and transfer of blastocysts into synchronized 
UGKO uteri also failed to establish a pregnancy (Gray et al. 2001b).  Similarly, progestin 
treatment of neonatal heifers compromises uterine gland development and increases pregnancy 
failure in adult heifers (Bartol et al. 1995). 
Failure of mated UGKO ewes to support pregnancy demonstrated the necessity of 
endometrial epithelia and their secretions for growth and elongation of the conceptus.  Flushings 
from UGKO ewes on Days 6 and 9 post-mating contained developmentally normal blastocysts 
suggesting that compaction and blastocyst differentiation are not dependent upon endometrial 
glands and their secretions (Gray et al. 2001b).  This is also evident in the success of in vitro 
produced blastocysts; however, sophisticated culture systems have failed to support development 
of embryos after hatching from the zona pellucida.  Flushings from UGKO ewes on Day 14 post-
mating contained severely growth retarded tubular conceptuses, approximately equivalent to 
morphology on Days 11 to 12 of pregnancy, and no detectable IFNT (Gray et al. 2001b).  
Restriction of ovine and porcine embryos to the oviductal environment, a milieu absent of 
endometrial glands and secretions, also results in failure of embryonic development beyond the 
blastocyst stage (Wintenberger-Torres 1956; Bazer 1975).  Thus endometrial glands and their 
secretory products are not required for development of the embryo to the hatched blastocyst 
state, but are unequivocally required for development to an elongated conceptus (Gray et al. 
2002). 
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Endometrial functions are influenced by the hormonal status of the female (Guillomot et 
al. 1988).  Continuous exposure of the uterus to P4 induces expression of GE secretory products 
that are collectively termed histotroph (Brinsfield and Hawk 1974; Salamonsen et al. 1985).  
Histotroph includes, adhesion proteins, cytokines, enzymes, hormones, growth factors, protease 
inhibitors, serum proteins, transport proteins, nutrients, eicosanoids, ions and other molecules yet 
to be discovered (Spencer et al. 2004b; Bazer et al. 2009).  A summary of factors known to 
comprise histotroph in sheep is presented in Table 2.1. 
 
  Table 2.1.  Factors known to comprise endometrial histotroph in sheep during early pregnancy. 
Factor 
Days 
Present 
 Reference 
Adhesion Molecules 
GLYCAM1 
Glycosylation dependent cell 
adhesion molecule 1 
13-19  (Spencer et al. 1999) 
IGFBP1 
Insulin-like growth factor 
binding protein 1 
12-20 (Simmons et al. 2009) 
LGALS15 
Lectin, galactoside-binding, 
secreted 15 
10-18  (Farmer et al. 2008) 
SPP1 
Secreted phosphoprotein 1 
(osteopontin) 
15-
parturition 
 (Johnson et al. 1999a) 
Cytokines 
B2M Beta-2-microglobulin 10-20  (Choi et al. 2003) 
CSF2 
Colony stimulating factor 
(granulocyte macrophage) 
17 (Imakawa et al. 1993) 
CXCL10  
Chemokine (C-X-C motif) 
ligand 10 
14-20 (Imakawa et al. 2006) 
LIF Leukemia inhibitory factor 4-20 (Vogiagis et al. 1997) 
MX1 
Myxovirus (influenza virus) 
resistance 1 
15-17 (Toyokawa et al. 2007) 
OAS 2',5'-oligoadenylate synthetase 11-19 (Johnson et al. 2001b) 
Enzymes 
CTSL Cathepsin L 10-20 (Song et al. 2005) 
Hormones 
GRP Gastrin-releasing peptide  18-120 (Song et al. 2008) 
STC1 Stanniocalcin 1 18-80, >120 (Song et al. 2006a) 
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Table 2.1 continued. 
Factor 
Days 
Present 
 Reference 
Growth Factors 
FGF2 
Fibroblast growth factor 2 
(basic) 
12-19 (Ocon-Grove et al. 2008) 
IGF1 Insulin-like growth factor 1 3-22 (Ko et al. 1991) 
IGF2 Insulin-like growth factor 2 10-16 (Ko et al. 1991) 
TGFB Transforming growth factor beta 12-20 (Imakawa et al. 1998) 
Protease Inhibitors 
CST3 Cystatin C 10-20 (Song et al. 2006b) 
TIMP1 
Tissue metallopeptidase 
inhibitor 1 
4-20 (Hampton et al. 1995) 
TIMP2 
Tissue metallopeptidase 
inhibitor 2 
4-20 (Hampton et al. 1995) 
UTMP Uterine milk proteins (serpins) 15-80, >120 (Stewart et al. 2000) 
Serum Proteins 
Endothelin 15-20 (Riley et al. 1994) 
Transport Proteins 
ISG15 ISG15 ubiquitin-like modifier 
13-25, >25-
150 
(Joyce et al. 2005) 
IGFBP3 
Insulin-like growth factor 
binding protein 3 
12-20 (Simmons et al. 2009) 
Nutrients 
Amino acids 
Arg, Gln, Leu, Asp, Glu, Asn, 
His, β-Ala, Tyr, Trp, Met, Val, 
Phe, Ile, Lys, Cys, Pro, 
Glutathione (tripeptide) 
10 < 16 (Gao et al. 2009) 
Ions Ca, Na, K 10 < 16 (Gao et al. 2009) 
Carbohydrate Glucose 10 < 16 (Gao et al. 2009) 
 
 
Progesterone induces histotroph secretion in a temporal manner to best accommodate 
blastocyst growth and conceptus development.  In embryo transfer, it is necessary for the donor 
and recipient uterine environments to be closely synchronized (Moore and Shelton 1964; Wilmut 
and Sales 1981).  When asynchrony was studied, embryos placed in a physiologically advanced 
uterine environment grow faster than synchronously transferred embryos; however, these 
embryos were unable to secrete IFNT by the appropriate time to circumvent luteolysis (Lawson 
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et al. 1983).  Additionally, placement of the transferred embryo in the uterine horn ipsilateral to 
the ovary with the CL, thus the horn with greatest P4 influence, increases pregnancy outcome 
(Sreenan et al. 1975).  Progesterone induction of histotroph is indeed temporal and spatially 
regulated within the maternal environment. 
Reproductive physiology of cattle has been negatively impacted over the past 50 years 
for the sake of improving production efficiencies (Archer et al. 1998; Lucy 2001).  Early 
pregnancy wastage in beef cattle is estimated to be at least 25% in beef cattle and 45% or greater 
in dairy cattle (Diskin and Sreenan 1980; Thatcher et al. 2001).  A majority of this loss (70-80%) 
occurs between Days 8 and 16 post-insemination (Sreenan and Diskin 1983; Diskin and Morris 
2008).  It is during this time frame that blastocyst growth to an elongated conceptus is crucial for 
producing IFNT, the pregnancy recognition signal.  Endometrial secretion, essential for initiating 
and mediating changes in blastocyst growth and conceptus differentiation, is regulated by the 
quantity and timing of P4 release from the CL into the circulation (Geisert et al. 1992).  In cattle, 
rapid blastocyst development and pregnancy establishment is positively correlated with 
increasing concentrations of circulating P4 (Sreenan and Diskin 1983; Mann and Lamming 
1999).   
Exogenous P4 administration has been the focus of research for the past seven decades 
in ameliorating the growing epidemic of embryonic mortality  (Wiltbank et al. 1956; Johnson et 
al. 1958; Sreenan and Diskin 1983; Van Cleeff et al. 1991; Mann and Lamming 1999; Villarroel 
et al. 2004; Mann et al. 2006; Forde et al. 2010; Forde et al. 2011).  Analysis of the research 
conducted over the years (presented in Table 2.2) suggests that exogenous P4 administration has 
moderate effects overall in enhancing pregnancy rates (Mann and Lamming 1999).   
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Table 2.2.  Summary of studies conducted to investigate effects of P4 supplementation on 
pregnancy rate in cattle.  Progesterone supplementation is presented for days post-mating 
and the duration of administration.  Effects on pregnancy are the overall impact of P4 
supplementation in comparison to control females, however no statistical comparisons are 
presented.   
Status 
Duration of P4 
supplementation 
Effect on 
Pregnancy 
Reference 
Repeat Breeding 
Heifers At breeding +30.0% (Henrick 1953) 
Dairy Heifers 3, 4 or 5 +30.1% (Dawson 1954) 
Dairy Cows selected for 
poor fertility  3-34 +11.9% (Wiltbank et al. 1956) 
Dairy Heifers and Cows 2-9 +32.3% (Johnson et al. 1958) 
Beef Heifers 10-20 +17.2% (Sreenan and Diskin 1983) 
Beef Heifers 5-Necropsy +28.7% (Sreenan and Diskin 1983) 
Lactating Dairy Cows 10-20 +1.9% (Sreenan and Diskin 1983) 
Lactating Dairy Cows 5-12 +30.7% (Robinson et al. 1989) 
Lactating Dairy Cows 10-17 +29.3% (Robinson et al. 1989) 
Lactating Dairy Cows 5-11 +10.9% (Walton et al. 1990) 
Lactating Dairy Cows 13-21 +7.6% (Stevenson and Mee 1991) 
Dairy Heifers 7-13 +4.3% (Van Cleeff et al. 1991) 
Lactating Dairy Cows 6-19 +2.5% (Villarroel et al. 2004) 
Lactating Dairy Cows 4-11; 5-12 +1.7% (Hanlon et al. 2005) 
Lactating Dairy Cows 3.5-10 +12.8% (Larson et al. 2007) 
 
 
The results of these studies suggest that P4 supplementation is beneficial when it elicits 
an early post-ovulatory rise in P4.  Concentration of P4 is not an absolute determinant of a 
successful pregnancy, but rather a factor which influences the probability of success or failure 
(Mann and Lamming 1999).  Research suggests P4 supplementation after Day 6 post-mating 
yields poor results whereas P4 supplementation before Day 6 results in 10% improvement in 
pregnancy rate (Mann and Lamming 1999).  Furthermore, if initial pregnancy rate was low 
(<50%), a greater improvement (19%) resulted from P4 supplementation; whereas, if initial 
pregnancy rate was high (>50%), there was no detectable benefit (Mann and Lamming 1999).  It 
may be beneficial for the environment of the conceptus to be affected by exogenous P4 if 
enhanced conceptus development can be achieved and advancement of IFNT secretion can be 
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realized to signal for the establishment of pregnancy.  This is especially true for the lactating 
dairy cow.  Increased liver blood flow resulting from elevated feed intake in lactating dairy cows 
fed to meet their demanding nutritional requirements, have increased steroid metabolism 
(Sangsritavong et al. 2002). 
From these studies it is clear that P4 supplementation has an effect on the developing 
blastocyst.  The effect is indirect and a result of downstream P4-induced changes in endometrial 
gene expression resulting in changes in the composition of histotroph to which the developing 
embryo is exposed (Geisert et al. 1992; Bauersachs et al. 2006; Spencer et al. 2007; Spencer et 
al. 2008; Clemente et al. 2009).  Current research being conducted regarding P4 supplementation 
is aimed at evaluating the transcriptome.  In beef heifers, supplemental P4 was found to change 
the temporal transcriptional profile of the endometrium during different developmental stages of 
the conceptus which contributed to or consequently advanced conceptus development (Carter et 
al. 2008; Forde et al. 2009).  Genes affected by P4 supplementation were associated with energy 
sources or contributors to histotroph (Forde et al. 2009). 
Levels of P4 during the postovulatory rise have been demonstrated to be positively 
associated with enhanced conceptus development in sheep.  In ewes, predisposed to either 
having short (15.9 ± 0.1 Days) or long (18.6 ± 0.4 days) estrous cycles, ewes with short cycles 
had greater concentrations of P4 on Days 2 to 4; but thereafter, concentrations of P4 were not 
statistically different between ewes with short or long estrous cycles (Nephew et al. 1991).  
Ewes with shorter estrous cycles had both advanced conceptus development and uterine 
environment by Day 13 as evidenced by the presence of filamentous conceptuses in uteri of ewes 
with short estrous cycles compared to no filamentous conceptus in uteri of ewes with longer 
estrous cycles.  Greater amounts of protein and IFNT were present in uterine flushes from ewes 
with short estrous cycles suggesting an enhanced uterine environment (Nephew et al. 1991).  
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Progesterone supplementation during early pregnancy affects fetal growth.  Administration of P4 
from Days 1 to 3 in ewes was demonstrated to significantly increase fetal growth on Day 74 of 
pregnancy (Kleemann et al. 1994).   
In a study conducted to identify genes regulating conceptus survival and elongation, 
Satterfield and colleagues (2006) developed a ewe model for advanced conceptus development 
by administering P4 from Day 1.5 post-mating to either Day 9 or Day 12.  They found P4-treated 
ewes had blastocysts with diameters 220% greater than those for control ewes on Day 9 
(Satterfield et al. 2006).  Further, Day 12 control ewes had spherical to slightly tubular 
blastocysts in contrast to elongated and filamentous conceptuses of P4-treated ewes.  In ewes 
treated with P4 from Days 1.5 to 8 and then treated Days 9 to 12 with RU486, a PGR antagonist, 
no blastocysts were recovered from the uterus.  Early P4 treatment enhanced blastocyst growth 
and development post-hatching from the zona pellucida; however, the time of blastocyst 
hatching was unaltered (Satterfield et al. 2006).   
In a subsequent study, Satterfield and colleagues (2009) used a microarray approach to 
identify the mechanisms by which P4 acts on the endometrium to advance conceptus 
development.  The Database for Annotation, Visualization, and Integrated Discovery (DAVID) 
identified biological networks differentially regulated on Day 9 versus Day 12 of pregnancy, 
Day 9 P4-treated versus control, and Day 12 P4-treated versus control ewes (Satterfield et al. 
2009).  Of particular importance, transport and transporter activity, and factors which stimulate 
cellular proliferation, migration, and attachment were differentially expressed.  Indeed, increases 
in expression of these genes would be expected as enhanced blastocysts growth requires an 
increase in composition and transport of histotroph, and conceptus development requires cellular 
proliferation and migration of trophectoderm cells at Day 12 of pregnancy. 
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Gene Profiles 
The following information presented in this section of the Literature Review focuses on 
candidate genes identified by microarray analysis.  Figure 2.2 summarizes regulation of 
candidate genes as found by Satterfield and authors (2009). 
 
 
Figure 2.2.  Progesterone regulated genes during early pregnancy in ovine endometrium.  Venn 
diagram illustrating endometrial genes up-regulated and/or down-regulated between Days 9 and 
12 of pregnancy and in response to early P4 treatment (Satterfield et al. 2009).  Genes 
highlighted in the boxes were selected for further mRNA expression analysis.  Adapted from 
(Satterfield et al. 2009).  
 
 
 
ANGPTL3 
Angiopoietin-like 3 (ANGPTL3) is structurally similar to the angiopoietin family, which 
function as secreted factors to facilitate in the cascade of angiogenesis, the proliferation of new 
blood vessels from pre-existing capillaries (Camenisch et al. 2002).  Upon ligand of ANGPTL3, 
the two termini of the structure induce varying functions.  The N-terminal coiled-coil domain 
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(CLD) increases plasma triglyceride levels in mice whereas the C-terminal fibrinogen-like 
domain (FLD) stimulates cell adhesion and migration (Gao et al. 2010).  Overexpression of 
ANGPTL3 in mice led to extremely high blood levels of triglycerides and cholesterol (Shan et al. 
2009).  Mostly produced in the liver and released into the circulation, ANGPLT3 stimulates 
adipose tissue lipolysis thereby raising free-fatty acid and glycerol levels in plasma (Lichtenstein 
and Kersten 2010).  Lipolytic processing of triglyceride-rich lipoproteins is mediated by 
lipoprotein lipase (LPL) to generate intermediate-density lipoprotein, low-density lipoprotein 
and chylomicron remnants.  LPL is tethered to capillary endothelium via heparin sulfate 
proteoglycans, and produced by adipocytes, cardiomyocytes and macrophages.  Expression of 
LPL is governed by the peroxisome proliferator activated receptor alpha (PPARA) and liver X 
receptor alpha (LXRA) in the liver.  Several modulators of LPL are known.  Specifically, 
ANGPTL3 suppresses LPL activity.  Consequently, uptake of fatty acids and cholesterol into 
tissues is decreased.  ANGPTL3 mRNA is markedly induced by activation of LXR that binds to a 
LXR response element in the ANGPLT3 promoter.  Whereas leptin and insulin down regulate 
ANGPTL3 mRNA expression (Lichtenstein and Kersten 2010). 
 In epithelia, ANGPLT3 has been implicated in cell adhesion and migration.  Podocytes 
are highly specialized epithelial cells with a complex cellular organization consisting of a cell 
body, major processes and foot processes.  Over expression of ANGPTL3 in podocytes 
significantly promoted the migration and permeability of the epithelia (Gao et al. 2010).   
Migration and cell adhesion of ANGPTL3 was conducted via integrin binding.  The FLD of the 
ANGPTL3 molecule does not bind Tie2, the angiopoietin family receptor, but rather integrin αvβ3 
to stimulate endothelial cell adhesion and migration.  Integrins are two-way signaling receptors 
responsible for the attachment of cells to the extracellular matrix (Camenisch et al. 2002).  
Integrin subunits α (v, 4, 5) and β (1, 3, 5) are constitutively expressed on the apical surfaces of 
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both conceptus trophectoderm and endometrial LE (Johnson et al. 2001a; Burghardt et al. 2002; 
Spencer et al. 2004a).  ANGPTL3 has not been evaluated in the uterus or during pregnancy.   
CHGA 
Chromogranin A (CHGA) gene is a precursor of biologically active peptides with 
endocrine, paracrine and autocrine functions.  Functional peptides include vasostatin, β-granin, 
chromostatin, pancreastatin and parastatin (Hendy et al. 1995).  The glycoprotein is acidic and 
hydrophilic, and involved in hormone packaging of secretory vesicles of many endocrine and 
neuroendocrine cells, and neurons.  CHGA is concentrated and stored within secretory granules 
and released into the extracellular environment with co-resident hormones after an appropriate 
stimulus (Ratti et al. 2000).  Hydrogen ion and calcium concentration can induce dramatic 
conformational changes of CHGA which contributes to the ability to sort peptide hormones and 
neurotransmitters, and package into secretory granules.  CHGA synthesis opposes its action on 
biosynthesis of the resident hormone.  In pituitary gonadotrophs, estradiol down-regulates 
CHGA gene expression and secretion, while enhancing luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) synthesis and secretion.  Thereby suppressing CHGA expression 
removes the inhibitory effect on the secretion of the resident LH and FSH to maximize secretion 
of estradiol (Hendy et al. 1995).  An intracellular mechanism of CHGA is the regulation of 
granule biosynthesis by controlling the stayability and availability of granule proteins at the 
posttranslational level.  Partial embryonic lethality occurred in Chga null mice.  Surviving Chga 
null mice must possess compensatory mechanisms however they demonstrate decreased number 
of granules with elevated levels of corticosterone.  This is likely attributed to the absence of 
CHGA down-regulating mechanism (Kim and Loh 2005).  Information of CHGA in the uterus or 
during pregnancy is unknown.   
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CLEC4E 
C-type lectin domain family 4, member E (CLEC4E) also termed Mincle (Macrophage-
inducible C-type lectin) is a C-type lectin receptor expressed in activated macrophages.  The C-
type lectin receptor (CLR) family of calcium-dependent carbohydrate binding lectins is a 
member of the innate immune receptor family.  Members also include toll-like receptors (TLR), 
nod-like receptor (NLR) and RIG-I-like receptors (RLR).  CLEC4E is highly up-regulated after 
exposure to various stimuli such as inflammatory cytokines and TLR ligands.  CLEC4E 
transduces activation signals through the immunoreceptor tyrosine-based activation motif 
(ITAM) containing adaptor protein, FcRγ, to induce secretion of pro-inflammatory cytokines, 
such as tumor necrosis factor alpha (TNFα), chemokine (C-X-C motif) ligand (CXCL) 1, 
CXCL2 and interleukin-6 (IL6)  to drive the recruitment of neutrophils (Crozat et al. 2009; 
Miyake et al. 2010).  Inflammatory mediators are the first molecules released in the milieu after 
innate immune cell activation.  Because they stimulate innate immune cells, they are considered 
the bridges between mechanisms of recognizing pathogens or altered self from self, and the 
induction of active effector functions (Crozat et al. 2009).  Information of CLEC4E in the uterus 
or during pregnancy is unknown.   
CXCL14 
Chemokine (C-X-C motif) ligand 14 (CXCL14), also known as BRAK, is a member of 
the chemokine family that consists of approximately 50 ligands and 20 receptors (Meuter et al. 
2007).  Chemokines are implicated in many functions such as angiogenesis, hematopoiesis and 
organogenesis (Locati and Murphy 1999).  CXCL14 is expressed ubiquitously in normal 
epithelial tissues but shows significantly decreased expression in tumor cells (Starnes et al. 2006; 
Meuter et al. 2007). CXCL14 is a chemoattractant for dendritic cells, activated monocytes, 
neutrophils and natural killer cells under differing physiological conditions (Kurth et al. 2001; 
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Shellenberger et al. 2004; Shurin et al. 2005; Starnes et al. 2006; Kuang et al. 2009a; Salogni et 
al. 2009).  CXCL14 is a potent mediator of tumor growth, invasion and metastasis, physiological 
occurrences which share similarities with trophectoderm invasion during implantation of 
invasive species (primates, humans, rodents) (Kirby 1965; Kuang et al. 2009a).  Loss of 
CXCL14 may allow tumor cells to escape mechanisms of immune surveillance and gain a 
selective advantage (Starnes et al. 2006).  Several chemokine receptors have been tested for the 
ligand however the receptor of CXCL14 remains to be elucidated. 
CXCL14 has been implicated in mice and human endometrial function during early 
pregnancy.  In mice, CXCL14 regulated trophectoderm invasion during implantation, a process 
similar to tumor invasion.  Biotinylated CXCL14 ligand was found to be bound by secondary 
trophectoderm giant cells of the ectoplacental cone at the fetomaternal interface (Kuang et al. 
2009a).  Dissimilar from other chemokines which could regulate trophectoderm migration in a 
similar method to that of leukocyte recruitment, CXCL14 does not play a promontory role and is 
shown to inhibit trophectoderm outgrowth and attachment (Kuang et al. 2009a).  CXCL14 was 
found to down-regulate blastocyst and EPC matrix metalloproteinase (MMP) 2 and 9, proteases 
which are capable of degrading extracellular matrix.  Thus the trophectoderm was unable to 
invade through the decidua to the maternal vasculature (Kuang et al. 2009a).  
In women, CXCL14 was expressed at the fetomaternal interface in first trimester 
implantation sites (Kuang et al. 2009b).  CXCL14 was highly regulated in human midsecretory 
endometrium compared to early secretory endometrium.  Furthermore, expression was high in 
cytotrophoblasts and moderate in decidualized stromal cells whereas no expression observed in 
extravillous trophoblast and syncytiotrophoblast, thereby expression may be regulated with 
trophoblast cell differentiation (Kuang et al. 2009b).  During the menstrual cycle, CXCL14 is 
expressed the highest during the P4 influenced secretory phase in uterine GE (Mokhtar et al. 
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2010).  CXCL14 was found to be transcriptionally regulated by P4 with at least two progesterone 
response elements (PRE) within the 2 kb promoter region of the gene (Mokhtar et al. 2010).   
EFNA1/EFNB1 
The Ephrin (EFN) families of ligands bind the EPH subfamily of receptor tyrosine 
kinases (RTK).  EFN/EPH signaling mediate many biological processes, including 
developmental and tumor angiogenesis, and embryogenesis (Katoh and Katoh 2006).  Ephrins 
are presented on the cell surface and attached to the membrane either through a 
glycosylphosphatidyl inositol (GPI) anchor or transmembrane domain.  Thus, EFNs have been 
divided into two subclasses, class A (GPI anchor) and B (transmembrane domain), dependent 
upon which type of membrane interaction (Kuijper et al. 2007).  Ligand and receptor binding is 
permissive.  Specificity of binding may be linked to cell specific expression.  EFN/EPH 
interaction does not promote cell proliferation during angiogenesis but rather mediate cell-cell 
attachment, cell-matrix contacts and cellular migration (Cheng et al. 2002).  EFN and EPH 
molecules mediate cell-cell attachment by the cadherin family.  Cadherins mediate cell 
interactions and have been implicated in embryo attachment during implantation (Singh and 
Aplin 2009).  Stimulation of EFNB1 induces integrin-dependent cell attachment and dissociation 
from extracellular matrices (Cheng et al. 2002).  EFNA1, an intermediate gene product of TNFα 
and vascular endothelial growth factor, has been proposed to induce endothelial cell migration 
during blood vessel assembly (Cheng et al. 2002).  Several EFN and EPH molecules are over-
expressed in tumor tissues and result in pathological angiogenesis (Kuijper et al. 2007).  During 
embryogenesis, EFN/EPH signaling regulates cell movements that establish germ layers, tissue 
boundaries, and vascular and neural networking, including axon pathfinding (Duffy et al. 2006).  
EFNA1 is localized to extravillous trophoblast cells of the invasive human placenta, suggesting 
EFNA1 expression to be critical for the migrating trophoblast which penetrates the maternal 
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uterine epithelia and spiral artery endothelium to establish hematotrophic source of nutrition 
(Goldman-Wohl et al. 2004; Fujii et al. 2011). 
FABP3 
Fatty acid binding protein 3 (FABP3), muscle and heart (also known as mammary-
derived growth inhibitor, MDGI) is a 15-kDa intracellular fatty acid binding protein.  Fatty acid 
binding proteins bind hydrophobic ligands in a reversible manner and mediate fatty acid 
metabolism (Hanhoff et al. 2002).  FABP3 is proposed to function in solubilization, 
transportation and energy homeostasis of fatty acids (Nevo et al. 2010).  Fabp3 null mice display 
alterations in cardiac long chain polyunsaturated fatty acid (LCPUFA) uptake and esterification 
into triglycerides and phospholipids (Storch and Thumser 2010).  Furthermore, arachidonic acid 
incorporation into triglycerides and phospholipids was decreased however phosphadtidylinositol 
and phosphatidyleserine were not affected, implying FABP3 involvement in lipid-mediated 
signal transduction (Storch and Thumser 2010). 
FABP3 has roles in growth inhibition and differentiation of the mammary gland from 
virgin to lactating state (Borchers et al. 1997).  FABP3 content in virgin mammary gland was 
lower in comparison to late and lactating rat mammary gland.  The induction of FABP3 was 
suggested to be mediated by lactogenic hormones (Borchers et al. 1997).  In mice, FABP3 
protein was up-regulated during cardiomyocyte differentiation and was associated with the 
inhibition of cardiomyocyte proliferation (Tang et al. 2004).  Interestingly, FABP3 expression 
was greater in human term syncytiotrophoblast that cytotrophoblasts, indicating differentiation 
as a regulator FABP3 expression (Daoud et al. 2005).  Additionally, the authors discovered 
LCPUFA linoleic acid efflux was greater in syncytiotrophoblasts and correlated with FABP3 
expression, thus increasing the amount of fatty acid transport via the placenta (Daoud et al. 
2005).  Fatty are required by the developing fetus to maintain fluidity, permeability and 
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conformation of membranes, as precursors of signaling compounds including prostaglandins, 
prostacylins, thromboxanes and leukotrienes, and as an energy source (Haggarty 2002).  FABP3 
role during early pregnancy has not been elucidated however expression has been identified in 
horse blastocysts (Smits et al. 2011) and cattle endometrium during early pregnancy (Forde et al. 
2011).  During late gestation, FABPs are important in facilitating the transfer of fatty acids 
across membranes and intracellular channeling (Haggarty 2002).  The deposit of LCPUFA to the 
fetus is rapid during growth and especially crucial for development of the brain (Duttaroy 2009). 
IFNG 
 Interferon gamma (IFNG), a Type II IFN, plays important roles in activating innate and 
adaptive immune responses, inhibiting cell proliferation and inducing apoptosis (Boehm et al. 
1997).  IFNG activates gene expression via JAK/STAT1 pathway (Bazer et al. 2009).  IFNG is 
produced primarily by natural killer (NK) cells (Murphy et al. 2009).  Activation of the innate 
immune system  by Type 1 IFNs and T-helper 1 (Th1) cells can be induced to synthesize and 
secrete IFNG (Murphy et al. 2009).  NK cells increase at implantation sites to regulate spiral 
artery remodeling and decidualization during early pregnancy in mice and humans  (Croy et al. 
2006).  Involvement of NK cells in ruminant pregnancy is not well understood (Hansen 2007).  
IFNG inhibits trophoblast invasion by down regulating expression of MMP2 and MMP9 (Hu et 
al. 2006; Lash et al. 2006).  IFNG may play a role in preventing excessive invasion of 
trophoblast cells during implantation (Murphy et al. 2009).  Of domestic species, IFNG is 
produced highest in pigs and is thought to have a synergistic role with IFN delta (IFND) in 
enhancing uterine receptivity by affecting polarity of uterine LE for remodeling (Bazer et al. 
2009).  
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IL6 
Interleukin 6 (IL6) is a pleiotrophic cytokine that is secreted as a 26-kDa soluble protein 
or complexed in a membrane-bound form with IL6 signal transducer (IL6ST, also known as 
gp130) (Taga and Kishimoto 1997; Kamimura et al. 2003; Robertson et al. 2010).  IL6 is 
ubiquitous and has diverse roles in hematopoiesis and the immune system as a regulator of 
inflammatory response (Robertson et al. 2010).  In the innate immune system, IL6 regulates the 
generation, recruitment, and functional phenotype of neutrophils, macrophages and dendritic 
cells (Romano et al. 1997; Mitani et al. 2000; Robertson et al. 2010).  In the adaptive immune 
response, IL6 stimulates production of antibodies by B cells, and in T cells to play a role in the 
Th1/Th2 balance (Muraguchi et al. 1988; Rincon et al. 1997). 
IL6 has been shown to be synthesized in the female reproductive tract and gestational 
tissues and appears to be involved in embryo implantation, placental development and the later 
stages of pregnancy (Robertson et al. 2010).  In vitro culture of human primary cytotrophoblasts 
cells demonstrated IL6 to stimulate cell migration and invasion by activation of MMP2 and 
MMP9 and integrin interaction (Jovanovic and Vicovac 2009).  IL6 deficient mice have reduced 
fertility and fewer viable implantation sites (Robertson et al. 2000).  Furthermore, IL6 acts in 
late gestation to accelerate the events of labor and mediates as link between declining P4 and 
induction of uterine activation genes for parturition (Robertson et al. 2010).   
A related cytokine, leukemia inhibiting factor (LIF) shares co-receptor IL6ST as IL6.  
LIF regulates the onset of uterine receptivity to blastocyst implantation and embryogenesis, and 
trophoblast giant cell differentiation in the placenta of mice (Vogiagis and Salamonsen 1999; 
Takahashi et al. 2008; Song et al. 2009).  Upon LIF binding to its receptor, LIF recruits IL6ST 
as a co-receptor.  The heterodimer complex activates JAK 1 or 2 and tyrosine kinase 2 (TYK2), 
and then STAT (particularly STAT3) to regulate gene expression (Auernhammer and Melmed 
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2000; Song et al. 2009).  Uterine LIF has been implicated in endometrial function, and conceptus 
growth and development during peri-implantation in sheep (Song et al. 2009).  Defective LIF 
production at the feto-maternal interface has been associated with pregnancy loss (Piccinni et al. 
2001).  
LGALS3  
Lectin, galactoside-binding, soluble, 3 (LGALS3) is a member of the β-galactoside-
binding lectins.  LGALS3 functions in cell growth (Barondes et al. 1994), apoptosis (Dumic et al. 
2006), mRNA processing (Liu et al. 2002), metastasis (Takenaka et al. 2004), differentiation and 
angiogenesis of endothelial cells (Nangia-Makker et al. 2000) mediation of inflammation and 
leukocyte adhesion (Almkvist and Karlsson 2004) and chemoattractant for monocytes and 
macrophages  (Sano et al. 2000).  In humans, LGALS3 is expressed throughout the menstrual 
cycle with highest expression in the secretory phase in uterine GE (von Wolff et al. 2005).  
Furthermore, LGALS3 is expressed on both trophoblast, epithelium and decidualized stroma, 
implicating LGALS3 in cell adhesion during implantation (von Wolff et al. 2005).  LGALS3 
modulates cell adhesion by binding to several ligands including laminin, fibronectin and 
integrins after its secretion from epithelial cells (Andre et al. 1999; Hughes 1999).  LGALS3 has 
been shown to be up-regulated in pathophysiological placentas (preeclamptic and intrauterine 
growth restricted) thus indicated to compensate for reduced trophoblast invasion based on results 
of LGALS3 role in initiating the adhesion of human breast and prostate carcinoma cells to 
endothelium (Jeschke et al. 2007).  Lgals3 null mutant mice show some effect on the survival or 
maintenance of neutrophils and macrophages at inflammatory sites and delayed phagocytosis 
(Poirier 2002; Sano et al. 2003; von Wolff et al. 2005).  Galectins are thought to be optimizing 
molecules based on survival of  Lgals3 and closely related Galectin-1 null mutant mice (Poirier 
2002). 
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LGALS3 has been identified in ruminants.  In sheep, LGALS3 is present in cotyledons 
during mid gestation and decreases at term (Iglesias et al. 1998).  LGALS3 has been localized in 
the cow uterine epithelium and glands, and macrophages during early pregnancy (Kim et al. 
2008). 
PTH 
Parathyroid hormone (PTH) contains an N-terminal conserved region that shares 
homology with PTH related peptide (PTHrP).  PTH regulates the placental expression of genes 
involving calcium and other solute transfer that contribute to the regulation of placental calcium 
transfer (Simmonds et al. 2010).  In the fetus, PTH is important for fetal calcium homeostasis.  
The fetal hypoparathyroid phenotype results in hypocalcemia, hypomagnesemia, 
hyperphospatemia, low amniotic fluid mineral content and reduced skeletal mineral content 
(Simmonds et al. 2010).  PTH and PTHrP share a common receptor, Type 1 PTH receptor 
(PTH1R) to stimulate via an endocrine-like pathway, bone resorption and renal calcium 
resorption (Clemens et al. 2001).  PTHrP has been implicated in uterine and placental tissues to 
play roles in regulating decidualization of stromal cells (Ferguson et al. 1998), modulating 
implantation and retention of the embryo (Williams et al. 1998), interaction of calcium binding 
and calcium sensing receptors to modulate trophoblastic outgrowth and differentiation (Nowak 
et al. 1999), and regulation of stretch and inhibition of oxytocin-stimulated activity during 
pregnancy in prevention of pre-term labor (Pitera et al. 1998; Clemens et al. 2001).  
RBP4 
Plasma retinol-binding protein 4, plasma (RBP4) is an intracellular transporter protein 
for retinol (Kanai et al. 1968).  Retinoids have numerous effects on cell and tissue biology 
during embryonic development and throughout pregnancy (Thompson 1969; Bates 1983; Wellik 
and DeLuca 1995).  RBP4 has been shown to be a major secretory product of the peri-
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implantation domestic conceptus and shown to significantly affect litter size in pigs (Harney et 
al. 1993).  Retinol influences the uniformity of embryos size and synchrony of development to 
improve the survival rate in pigs (Trout et al. 1991).  Interestingly, RBP4 is a candidate gene for 
litter size in pigs (Harney et al. 1993; Rothschild et al. 2000).  RBP4 also has roles as an 
adipocytokine which is synthesized by adipocytes or macrophages from adipose tissues.  RBP4 
concentrations have been reported to be higher in women with late-onset preeclampsia than in 
normal, late pregnancy controls and is thought to play a role in the pathophysiology of obese 
women with late-onset preeclampsia via increased insulin resistance (Masuyama et al. 2011).   
SLIT2/SLIT3 
Slit homolog 2 (SLIT2) and slit homolog 3 (SLIT3) are ligands for the roundabout 
(ROBO) transmembrane receptor.  SLIT-ROBO interactions are implicated in the development of 
the nervous system by acting as guidance cues in developing organs (Hinck 2004; Andrews et al. 
2007).  Additionally, SLIT2 has been shown to block vascular endothelial growth factor and 
epidermal growth factor mediated migration of endothelial cells, and inhibits migration of 
leukocytes (Guan et al. 2003).  Whereas, SLIT3 has been discovered to enhance monocyte 
migration and myeloid cell recruitment during inflammation, therefore SLIT3 promotes 
leukocyte migration (Geutskens et al. 2010).   
SLIT2 and SLIT3 are expressed in endometrium throughout the menstrual cycle, with 
SLIT3 significantly up-regulated in mid-secretory phase endometrium (Duncan et al. 2010).  
Both SLIT2 and SLIT3 mRNA was decreased in decidua tissue during early pregnancy.  SLIT2 
protein was shown to be expressed in uterine LE and GE, and to a lesser extent in stromal cells 
near LE.  SLIT2 expression was not affected by hormone steroids in vitro (Dickinson and 
Duncan 2010).  The SLIT-ROBO pathway is also expressed in ovarian tissue.  Cortisol 
negatively regulates SLIT2 and SLIT3 expression in primary cultures of luteal fibroblast-like 
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cells and luteinized granulosa cells (Dickinson and Duncan 2010).  SLIT-ROBO pathway also 
hindered migration of these cells and increased apoptosis.  Their activity is thought to promote 
luteolysis and SLIT-ROBO expression is hormonally regulated in the adult CL (Dickinson and 
Duncan 2010). 
VWF 
von Willebrand Factor (VWF) is a large multimeric plasma glycoprotein involved in 
normal homeostasis.  VWF mediates platelet adhesion and acts as a carrier molecule for 
coagulation factor VIII, to protect from proteolytic degradation (McGrath et al. 2010).  VWF is 
synthesized by megakaryocytes and stored within α-platelets, and by endothelial cells, stored 
within the Weibel-Palade bodies (Meyer et al. 1991).  VWF unique localization to endothelial 
cells has resulted in the use of VWF as an endothelial cell marker for immunohistochemistry.  
However, VWF expression is heterogenous with higher expression occurring in venous than 
arterial vasculature (Zanetta et al. 2000).  VWF expression has been shown to be up-regulated by 
fibroblast growth factor 2 and vascular endothelial growth factor during angiogenesis, thus 
indicating VWF expression as a detector of angiogenesis in tumor growth (Zanetta et al. 2000). 
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CHAPTER III 
PROGESTERONE REGULATION OF ENDOMETRIAL  
GENE EXPRESSION IN THE EARLY PREGNANT OVINE UTERUS 
 
Introduction 
The maternal environment to which the developing conceptus is exposed following 
hatching from the zona pellucida is physiologically crucial in survival and growth of the 
conceptus (embryo and associated extraembryonic membranes).  In sheep, the morula stage 
embryo enters the uterus on Days 4 to 5 post-mating.  The morula will develop into a blastocyst 
that contains an inner cell mass and blastocoele surrounded by a monolayer of trophectoderm 
(Guillomot 1995).  On Day 10, the hatched blastocyst is spherical, 0.4 to 0.9 mm in diameter 
with approximately 3000 cells (Wintenberger-Torres and Flechon 1974).  The blastocyst will 
transition from spherical to tubular to filamentous morphology.  By Day 12, the tubular 
blastocyst is 10-22 mm in length, and elongated to 10 cm on Day 14 resembling a filamentous 
form (Wintenberger-Torres 1956).  The trophectoderm increases 90-fold from Day 13 to 19 
resulting in the elongation of the conceptus into the contralateral uterine horn of ovulation 
(Wales and Cuneo 1989).  During elongation, the ruminant conceptus produces and secretes the 
maternal recognition of pregnancy signal, IFNT from the monolayer trophectoderm (Bazer et al. 
1979; Spencer et al. 2008).  IFNT inhibits development of the mechanism for release of 
luteolytic pulses of prostaglandin F2α from the uterine epithelia, thereby maintaining a 
functional corpus luteum (CL) and its production of progesterone (P4) required for pregnancy 
(Bazer et al. 1996).  IFNT must be secreted by the elongating conceptus between Days 12 and 16 
for a successful pregnancy outcome (Spencer and Bazer 2004a).   
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During early pregnancy under the continuous exposure of progesterone (P4) from the 
corpus luteum, the maternal environment synthesizes and secretes or transports a complex 
variety of substances, collectively termed histotroph, into the uterine lumen to nourish the 
developing embryo/conceptus.  Histotroph is an array of adhesion proteins, cytokines, enzymes, 
hormones, growth factors, protease inhibitors, serum proteins, transport proteins, and other 
substances (Spencer et al. 2004b; Bazer et al. 2009).  Endometrial glands and their secretions are 
vital to embryo/conceptus development in domestic species because of the protracted peri-
implantation period (Bazer et al. 1979).  Uterine gland knock out (UGKO) ewes contain a 
uterine milieu absent of endometrial glands and secretions along with reduced uterine LE due to 
epigenetic ablation by inappropriate exposure of progestin during neonate life (Gray et al. 
2000b; Gray et al. 2001b).  UGKO phenotype results in failure of embryonic development 
beyond the blastocyst stage thus demonstrating the importance of endometrial epithelia and their 
secretions on blastocyst development.  Furthermore, studies of asynchrony between transferred 
embryos and the uterus have demonstrated the importance of the coordinate temporal 
relationships between endometrial secretions during early pregnancy and conceptus development 
(Pope 1988).   
Satterfield et al. (2006) reported an ovine model of accelerated blastocyst development 
elicited by advancing the postovulatory rise in circulating levels of P4 during metestrus.  
Exogenous P4 administered to ewes from 36 h after onset of estrus had blastocysts on Day 9 
with increased diameter and on Day 12, conceptuses were filamentous compared to spherical and 
tubular conceptuses in uteri of control (Satterfield et al. 2006).  Their results indicate marked 
effects of early P4 supplementation on pre-implantation growth and development of blastocysts.  
Analyzing the endometrial transcriptome of P4 supplementation ewes by microarray, Satterfield 
et al. (2009) identified novel candidate genes and regulatory pathways governing P4 regulation 
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of peri-implantation blastocyst growth and conceptus development (Satterfield et al. 2009).  The 
objective of this study was to validate P4 regulation of candidate genes by quantitative PCR in 
early P4-treated ovine endometrial tissues during early pregnancy.   
 
Materials and Methods 
Animals 
Mature crossbred Suffolk ewes (Ovis aries) were observed daily for estrus in the 
presence of intact vasectomized rams and were used in experiments only after having exhibiting 
two estrous cycles of normal duration (16-18 Days).  All experimental and surgical procedures 
were in compliance with the Guide for the Care and Use of Agriculture Animals in Research and 
Teaching and approved by the Institutional Animal Care and Use Committee of Texas A&M 
University. 
Experimental Design  
At estrus (Day 0), ewes were mated to an intact ram and assigned randomly to receive 
daily intramuscular injections beginning 36 hours after onset of estrus of either: corn oil (CO) 
through Day 9 (9CO, n =4) or through Day 12 (12CO, n = 5); 25 mg P4 in CO (Sigma Chemical, 
St. Louis, MO) through Day 9 (9P4, n=5) or through Day 12 (12P4, n = 5); or 25 mg P4 in CO 
through Day 8 and 75 mg mifepristone (RU486; Sigma Chemical Co.), a P4 receptor and 
glucorticoid receptor antagonist (Baulieu 1989), from Day 8 through Day 12 (P4+RU486; n=5), 
as described previously (Satterfield et al. 2006).  Ewes were hysterectomized on either Day 9 or 
Day 12 of pregnancy.  At hysterectomy, sections (~0.5 cm) from the midportion of each uterine 
horn ipsilateral to the CL were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2).  After 24 h, 
fixed tissues were changed to 70% ethanol (v/v) for 24 h, dehydrated through a graded series of 
alcohol to xylene, and then embedded in Paraplast-Plus (Oxford Labware, St. Louis, MO).  The 
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remaining endometrium of the ipsilateral uterine horn was physically dissected from the 
myometrium, frozen in liquid nitrogen, and stored at -80⁰C for subsequent RNA extraction.  No 
tissues from the contralateral uterine horn in monovulatory pregnant ewes were used for 
analysis. 
RNA Isolation and Quantitative Real-Time PCR Analysis 
Total cellular RNA was isolated from frozen ipsilateral endometrium using Trizol 
reagent (Gibco-BRL, Bethesda, MD) according to manufacturer’s instructions.  The quantity and 
quality of total RNA were determined by spectrometry and by denaturing agarose gel 
electrophoresis, respectively.  Total RNA samples were digested with RNase-free DNase I and 
were cleaned up using the RNeasy MinElute Cleanup Kit (Qiagen, Valencia, CA). 
Total RNA from each sample was reverse transcribed in a total reaction volume of 20 µl.  
Briefly, 5 µl RNA was combined with primer mix containing oligo (dT) primer (0.2 µg/µl), 
random hexamer primer (3 µg/µl) (Invitrogen, Carlsbad, CA) and incubated at 70⁰C for 10 
minutes.  A reverse transcriptase (RT) mix containing 5X first-stand buffer, RNasin, 100 mM 
dNTP, 100 mM DTT and SuperScript II RTase (Invitrogen, Carlsbad, CA) was added to the 
reaction and reverse transcription performed under following conditions: 42⁰C for 90 min and 
95⁰C for 2 min.  Complementary DNA (cDNA) preps were cleaned by phenol-choloroform 
extraction and acid-ethanol precipitation, resuspended in 20 µl of water and stored at -20⁰C.  
Control reactions in the absence of reverse transcriptase were prepared for each sample to detect 
genomic DNA contamination.  
Quantitative PCR (qPCR) was performed using the ABI prism 7900HT system (Applied 
Biosystems, Foster, CA) with Power SYBR Green PCR Master Mix (Applied Biosystems, 
Foster, CA) as specified by manufacturer.  Specific oligonucleotide primers were designed and 
analyzed by Oligo 5 (Molecular Biology Insights, Inc).  Forward and reverse primer sequences 
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for all genes analyzed are listed in Table 3.1.  Primer specificity and efficiency (-3.2077 > 
threshold curve > -3.447) were confirmed using a test amplification run.  Each individual sample 
was run in triplicate using the following conditions: 50⁰C for 2 min, 95⁰C for 10 min; and then 
95⁰C for 15 sec and 60⁰C for 1 min for 40 cycles.  A dissociation curve was generated to 
determine amplification of a single product.  The threshold line was set at the linear region of the 
plots above the baseline noise, and threshold cycle (CT) values were determined at the cycle 
number at which the threshold line crossed the amplification curve.  The results are expressed in 
terms of change in CT values (CT).  To adjust for variations in the amount of cDNA, the mean 
CT values for each gene were normalized against average CT values for the reference gene (ovine 
alpha-tubulin, TUBA) as follows: CT = mean CT specific gene – mean CT TUBA.  Subtraction of an 
arbitrary constant from CT, generated CT.  Finally, the relative quantification (RQ) of each 
gene was calculated as 2
-C
T.   
Statistical Analysis 
  Relative quantification values were subjected to least-squares analysis of variance using 
the General Linear Models procedures of the Statistical Analysis System (SAS Institute, Cary, 
NC).  P < 0.05 was regarded as significant.  Data are presented as least squares means with 
overall standard errors. 
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Table 3.1.  Candidate Entrez gene symbol, gene name, accession number and forward and reverse primer sequences for all genes. 
Entrez Gene 
Symbol Gene Name 
Accession 
Number Forward Primer Reverse Primer 
ANGPTL3 Angiopoietin-like 3  NM_001080345 GAAGAGCGACATCCAAACTG GGTTAATTGGTCCTCCAGGT 
CHGA Chromogranin A  NM_181005 CCTCCCCAGCCCGAAATAC TGTCTGCCTCCCTTGCTCT 
CLEC4E 
C-type lectin domain family 4, 
member E XM_592701 GGCAATGGGTAGATGGTACA CTTATGGTGGCACAGTCCTC 
CXCL14 
Chemokine (C-X-C motif) 
ligand 14 NM_001034410 GACCCAAGATCCGCTACAG AACCATCTTCTCCTCGCAGT 
EFNA1 Ephrin-A1 NM_001034292 GCAAAATCACTCACAGCCCT GGTCATCTGCTGGAAGTCTC 
EFNB1 Ephrin-B1 NM_001080299 CCGACAGCTTCTTCAACTCC CAGCTTCAGTAGCAGGATGG 
FABP3 
Fatty acid binding protein 3, 
muscle and heart (MDGI) NM_174313 AAATTCTCCTGGGGTCAGGT GCCTTGGCTCTGCTTTATTG 
IFNG Interferon, gamma NM_001009803 GCTCTGTGTGCTTTTGGGTT GCTACATCTGGGTTACTTGC 
IL6 Interleukin 6 (interferon, beta 2) NM_001009392 GAGGGAAATCAGGAAACTGT CTCGTTTGAGGACTGCATCT 
LGALS3 
Lectin, galactoside-binding, 
soluble, 3 NM_001102341 CTGGGGAAAGGAAGAAAGAC GTCAGGTTCAACCAGCACTT 
PTH Parathyroid hormone  AF327654 GACTTACGGCGTCGGTTCTT GCTCTGATTTCGGCTGTGTG 
RBP4 
Retinol binding protein 4, 
plasma  NM_001040475 TCCAGAAAGGAAACGATGAC GGCAAACACGAAAGAGTAGC 
SLIT2 Slit homolog 2  EF627036  CCAGATCACATTCCCCAGTA GATCCCAGTAGCTTCCAACA 
SLIT3 Slit homolog 3  EF627037 ACCAGTACGAGTGCCAGAAT GTTGACGGTGATGAGCTTCT 
TUBA Tubulin, alpha AF251146 GGTCTTCAAGGCTTCTTGGT CATAATCGACAGAGAGGCGT 
VWF Von Willebrand Factor XM_584169 GTGCTGTGACACATGTGAGG CCTGGCAGTAGTGAATGTCC 
4
3
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Results 
 
Table 3.2.  Fold changes in mRNA levels of candidate genes in the ovine endometrium as 
determined by microarray and qPCR analyses.  NC, no fold change observed for microarray 
comparison.  Data presented as fold change;   
a 
P<0.001, 
b
 P≤0.05 for the qPCR comparison. 
Entrez 
Gene 
Symbol Method 
D12 CO 
vs.      
D9 CO 
D9 P4 
vs. 
 D9 CO 
D12 P4 
vs.  
D12 CO 
ANGPTL3 Microarray 2.8 NC NC 
 
qPCR 2.1
a
 -1.1 -1.2 
CHGA Microarray 3.0 3.5 NC 
 
qPCR 4.3
b
 3.7 1.2 
CLEC4E Microarray 2.2 NC NC 
 
qPCR -1.5 1.2 1.1 
CXCL14 Microarray 18.4 17.6 NC 
 
qPCR 15.5
b
 13.7
b
 1.0 
EFNA1 Microarray 3.3 NC NC 
 
qPCR 2.1
b
 1.3 1.1 
EFNB1 Microarray 2.4 NC NC 
 
qPCR 2.2
a
 1.4 -1.1 
FABP3 Microarray NC NC 3.9 
 
qPCR 1.4 1.2 1.4
b
 
IFNG Microarray -2.5 -3.6 NC 
 
qPCR -1.1 -1.1 1.9
b
 
IL6 Microarray NC NC 3.0 
 
qPCR 1.2 1.7 7.5
a
 
LGALS3 Microarray NC NC 2.2 
 
qPCR 2.1
b
 1.6 1.5
b
 
PTH Microarray 4.5 3.2 -2.3 
 
qPCR 1.1 1.3 1.1 
RBP4 Microarray 2.1 NC NC 
 
qPCR 2.3
b
 1.6 -1.1 
SLIT2 Microarray 2.2 NC NC 
 
qPCR 2.3 1.6 1.3 
SLIT3 Microarray 2.5 NC NC 
 
qPCR 1.3 1.1 -1.1 
VWF Microarray 3.5 NC NC 
  qPCR 1.1 1.2 1.2 
 45 
Figure 3.1.  Effect of treatment in control (CO), progesterone (P4) or P4 and RU486 (P4+RU) 
endometrial mRNA.  Relative quantification of A) ANGPTL3, B) CHGA, C) CXCL14, D) 
EFNA1, E) EFNB1, F) FABP3, G) IFNG, H) IL6, I) LGALS3 and J) RBP4 mRNA determined by 
qPCR.  Comparisons made for day (†) and treatment (*), significance level, P < 0.05.  Data 
presented as least-square mean RQ with standard error (SE). 
 46 
 
 47 
Microarray and qPCR data are summarized in Table 3.2.  Quantitative PCR confirmed 
effects of P4 and day of pregnancy on expression of ANGPTL3, CHGA, CXCL14, EFNA1, 
EFNB, FABP3, IL6, RBP4, and SLIT2 in the endometrium of the ovine uterus.  Early P4 
treatment or day did not affect (P > 0.10) expression of CLEC4E, PTH, SLIT2, SLIT3 and VWF 
mRNAs.  Those genes in which comparisons of day and/or treatment were significant are 
presented in Figure 3.1.   
Gene Regulation by Day  
 Gene expression up-regulated from Day 9 to Day 12 of pregnancy in the ovine 
endometrium included ANGPTL3, CHGA, CXCL14, EFNA1, EFNB1, LGALS3 and RBP4.  The 
following fold increases occurred from Day 9 to Day 12 in control CO treatment endometrium: 
ANGPTL3 mRNA increased (P < 0.001) 2.1-fold; CHGA mRNA increased (P < 0.05) 4.3-fold; 
CXCL14 increased (P < 0.05) 15.5-fold; EFNA1 increased (P < 0.05) 2.1-fold; EFNB1 increased 
(P < 0.0001) 2.2-fold; LGALS3 increased (P < 0.05) 2.1-fold; and RBP4 increased (P < 0.01) 
2.3-fold. 
Gene Regulation by Treatment 
 CXCL14 mRNA increased (P = 0.05) 13.7-fold in P4-treated endometrium on Day 9 in 
comparison to control on Day 9.  Gene mRNA levels were up-regulated in P4-treated 
endometrium on Day 12 in comparison to control Day 12 endometrium for FABP3, IFNG, IL6 
and LGALS3.  FABP3 mRNA increased (P = 0.05) 1.4-fold, IFNG mRNA increased (P < 0.05) 
1.9-fold, IL6 mRNA increased (P < 0.0001) 7.5-fold, and LGALS3 increased (P < 0.05) 1.5-fold.  
Progesterone and RU486 treatment down-regulated mRNA of ANGPTL3 2.7-fold (P < 0.0001), 
CHGA 16.3-fold (P < 0.01), EFNA1 6.8-fold (P < 0.0001), EFNB1 2.5-fold (P < 0.0001), 
FABP3 1.8-fold (P < 0.01), IFNG 3.8-fold (P < 0.001), IL6 10.7-fold (P < 0.0001), LGALS3 3-
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fold (P < 0.001), RBP4 2.4-fold (P < 0.01), SLIT2 3.7-fold (P < 0.05), SLIT3 4-fold (P < 0.05) 
and VWF 3-fold (P < 0.01) compared to Day 12 P4-treated endometrium.      
 
Discussion 
The present study validated candidate genes by qPCR analysis that were originally 
identified by microarray analysis to be implicated in effects of P4 on peri-implantation blastocyst 
growth and conceptus development.  Similar mRNA expression by qPCR analysis that validated 
microarray data was observed for  ANGPTL3, CHGA, CXCL14, EFNA1, EFNB, FABP3, IL6, 
RBP4, and SLIT2.   
 Results for CLEC4E, PTH, SLIT2, SLIT3 and VFW from qPCR did not indicate any 
difference for day of pregnancy or treatment (CO vs. P4); however SLIT2, SLIT3 and VWF were 
down-regulated in P4+RU endometrium compared to P4-treated endometrium on Day 12 of 
pregnancy.  RU486 inhibits the function of both PGR and glucocorticoid receptors.  Ewes that 
received P4+RU treatment were not exposed to continuous P4 thereby PGR was not down-
regulated.  SLIT2, SLIT3 and VWF expression was not up-regulated by P4 treatment in either day 
however they were down-regulated in P4+RU treated endometrium.  Flushings of the P4+RU 
treated uteri did not contain any conceptuses.  Glucocorticoids inhibit both SLIT and receptor, 
ROBO expression in ovarian cells (Dickinson and Duncan 2010).  The significant decrease of 
mRNA levels for SLIT2 and SLIT3 in P4+RU486 endometrium may be the result of RU486 
binding the steroid response elements of these genes thereby affecting transcription of SLIT2 and 
SLIT3 (Duncan et al. 2010).  VWF is unique to endothelial cells and is used as a marker for 
tumor angiogenesis, the generation of new vessels from pre-existing vasculature.  Angiogenesis 
must occur in placental tissues to meet the hematotrophic needs of the fetus.  Angiogenic 
molecules are not shown to be up-regulated in pregnancy until Days 20-30 (Grazul-Bilska et al. 
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2011).  Therefore, it is discernible for VWF to not be affected by day or treatment in the scope of 
the present study.   
 ANGPTL3 was shown to be regulated by day according to microarray data.  Quantitative 
PCR confirmed ANGPTL3 regulation by day of pregnancy with greatest mRNA levels observed 
in Day 12 pregnant endometrium.  Furthermore, P4+RU treatment down-regulated ANGPTL3 
mRNA.  ANGPTL3 induction occurs during the decline and loss of PGR (Spencer and Bazer 
1995).  Additionally, ANGPTL3 was down-regulated in endometrium of P4+RU treatment, 
which still express LE and GE PGR.  These results indicate ANGPTL3 to be regulated by P4, 
via down-regulation of PGR.  ANGPTL3 is a secreted glycoprotein that has been shown to be 
expressed in human umbilical venous endothelial cells and human microvascular vein 
endothelial cells to stimulate cell adhesion and migration via integrin αvβ3 (Camenisch et al. 
2002).  ANGPTL3 may play a role in the migration of trophectoderm and adhesion of the 
conceptus to uterine LE via integrin subunits α (v, 4, 5) and β (1, 3, 5) that are constitutively 
expressed on the apical surfaces of both conceptus trophectoderm and endometrial LE (Johnson 
et al. 2001a; Burghardt et al. 2002; Spencer et al. 2004a).   
 CHGA mRNA was regulated by day of pregnancy with greater levels detected in Day 12 
control endometrium.  These results are in agreement with microarray data.  CHGA was also 
down-regulated in P4+RU treated endometrium.  Thus, CHGA is indicated to be regulated by P4 
via the loss of PGR.  CHGA is a ubiquitous protein which is stored in secretory granules of the 
endocrine, exocrine and nervous systems, along with their respective hormones, enzymes, and 
neuropeptides and neurotransmitters to regulate secretory granule biosynthesis (Kim and Loh 
2005).  Under continuous P4 secretion, the endometrium produces and secretes histotroph to 
nourish the developing conceptus.  CHGA may be implicated as a co-secretory granule product 
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of endometrial secretions, thus observing an increase from Day 9 to Day 12 would be anticipated 
with increased histotrophic production by the endometrium under continuous P4. 
CXCL14 mRNA was regulated by early P4 treatment on Day 9 and by day of pregnancy, 
with greater mRNA levels in Day 12 control endometrium.  Thus, CXCL14 is regulated by P4.  
CXCL14 is expressed in mice and humans during early pregnancy.  In mice, CXCL14 expression 
was induced at the embryo implantation site and expanded with decidualization.  In vitro studies 
revealed CXCL14 as an inhibitory factor against trophoblast outgrowth by down regulating 
MMP2 and MMP9 activity.  CXCL14 was suggested to balance the invasive ability of 
trophoblast against other promoting chemokines (Kuang et al. 2009a).  Similar results were 
observed in women regarding suppression of MMP9 activity.  CXCL14 was localized to villous 
cytotrophoblasts, moderately to decidualized stroma and very weakly in syncytiotrophoblasts 
and extravillous trophoblast during the first trimester (Kuang et al. 2009b).  Additionally, 
CXCL14 was found to be highly up-regulated during the mid-secretory phase of the menstrual 
cycle in women.  Indeed, CXCL14 contains progesterone response elements (Mokhtar et al. 
2010).  In pigs, CXCL14 expression increased during conceptus elongation (Ross et al. 2009).  
Satterfield et al. (2009) reported CXCL14 mRNA expressed exclusively in the endometrial LE 
and GE of P4-treated endometrium on Days 9 and 12 and Day 12 control endometrium.  
CXCL14 may have implications in trophectoderm elongation by balancing the effects of 
promoting chemokines (Salamonsen et al. 2007).  Therfore, CXCL14 may serve to maintain 
synchrony of the conceptus with the maternal environment in ovine during early pregnancy.   
 EFNA1 and EFNB1 mRNA levels were both regulated by day with greater expression in 
Day 12 endometrium.  Additionally, P4+RU treatment in Day 12 endometrium attenuated 
expression of EFNA1 and EFNB1.  These results indicate EFNA1 and EFNB1 to be regulated by 
P4.  The EFN family is involved in migration and guidance of axons during embryogenesis and 
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angiogenesis, specifically mediating cell-cell contacts, cell adhesion to extracellular matrix and 
cell migration (Cheng et al. 2002). EFNA1 is expressed in human uterine LE (Fujii et al. 2011).  
Authors evaluated in vitro actions of EFNA1, using human endometrial carcinoma cells, which 
show expression profiles of EFN molecules similar to normal uterine LE.  EFNA1 was proposed 
to promote the intracellular dissociation of LE during implantation.  EFNB1 modulates integrin-
mediated cell attachment and migration during angiogenesis via αvβ3 and αvβ5 subunits (Huynh-
Do et al. 2002).   
FABP3 mRNA levels were increased in Day 12 P4-treated endometrium.  Interestingly, 
FABP3 is P4-regulated in bovine endometrium during early pregnancy and thought to contribute 
to histotroph composition (Forde et al. 2009).  In the sheep, FABP3 may be P4-regulated, 
however expression was not up-regulated in Day 9 P4-treated endometrium or in Day 12 CO 
endometrium.  Increased FABP3 mRNA level in Day 12 P4-treated endometrium is associated 
with IFNT secretion from the trophectoderm.  Thus, FABP3 is likely induced by IFNT, as are a 
number of classical and non-classical IFN stimulated genes.  The function of FABP3 remains 
elusive however, it is proposed to function in intracellular solubilization, transportation and 
energy homeostasis of fatty acids (Nevo et al. 2010).  Up-regulation of FABP3 by conceptus 
factors, likely increases intracellular fatty acid trafficking thus making fatty acids readily 
available.  Fatty acids during early pregnancy are important for synthesis of eicosanoids (PGs, 
tromboxanes and leukotrienes) (Mattos et al. 2000),  maintaining cellular and organelle integrity 
(Duttaroy 2009), and mediating gene expression (Sampath and Ntambi 2005). 
IFNG was up-regulated in Day 12 P4-treated endometrium.  These results indicate IFNG 
to be regulated by IFNT from the conceptus.  IFNG plays roles in diverse cellular processes, 
including activation of innate and adaptive immune responses, inhibiting cell proliferation, and 
inducing apoptosis (Boehm et al. 1997; Murphy et al. 2009).  Interestingly, activation of IFNG 
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production in innate immune cells is typically preceded by signaling from type 1 IFN (Murphy et 
al. 2009).  Thus IFNT (Type 1 IFN) produced by advanced filamentous conceptuses in Day 12 
P4 treatment may be up-regulating endometrial IFNG mRNA. 
Similar to cytokine IFNG, IL6 was greatest in Day 12 P4-treated endometrium.  Thus, 
IL6 is also implicated as being induced by IFNT from the advanced conceptus in Day 12 P4-
treated endometrium.  In humans, IL6 is increased in mid-secretory phase, predominantly in LE 
and GE (Dimitriadis et al. 2005).  IL6 is a pleiotrophic cytokine that belongs to the IL6 signal 
transducer receptor cytokine family which also includes LIF.  Interestingly, LIF is regulated by 
P4 and IFNT in the ovine uterus (Song et al. 2009).  LIF is implicated in conceptus growth and 
differentiation of the trophectoderm in sheep, based off observation of trophoblast giant cell 
differentiation in mice (Takahashi et al. 2008).  In vitro studies of IL6 in human extravillous 
trophoblast cells demonstrate IL6 to stimulate cell migration and invasion by up-regulation of 
integrin subunits α1, α5 and β1 and activation of MMP2 and MMP9 (Jovanovic and Vicovac 
2009).  Song et al. (2009) identified IL6ST, the co-receptor of IL6 and LIF in sheep, thus this 
molecule may be involved in stimulating conceptus growth and migration in the ewe. 
LGALS3 mRNA was up-regulated in Day 12 control endometrium and in P4-treated 
endometrium on Day 12.  These results indicate LGALS3 to be induced by P4 and stimulated by 
IFNT from the trophectoderm.  LGALS3 is expressed in cow LE and GE during early pregnancy 
(Kim et al. 2008).  In humans, LGALS3 is highly expressed during the secretory phase of the 
menstrual cycle.  During pregnancy LGALS3 is expressed on both trophoblast, epithelium and 
decidualized stroma (von Wolff et al. 2005).   LGALS3 modulates cell adhesion by binding to 
several ligands including laminin, fibronectin and integrins after its secretion from epithelial 
cells (Andre et al. 1999; Hughes 1999).  Family member, LGALS15 is induced by P4 and 
stimulated by IFNT, of which LGALS3 shares a similar expression profile (Satterfield et al. 
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2006).  LGALS15 functions as a cell adhesion molecule that bridges integrins between uterine 
LE and trophectoderm (Farmer et al. 2008).  LGALS3 may serve in a similar fashion as an 
adhesion molecule in sheep. 
RBP4 mRNA was up-regulated in Day 12 control endometrium compared to Day 9 
control endometrium and down-regulated by P4+RU treatment, indicating RBP4 to be 
stimulated by P4.  RBP4 binds retinol and has been shown to significantly affect litter size in 
pigs (Harney et al. 1993).  Retinoids control cell growth, differentiation and death (Gomez et al. 
2006).  In pigs, the most advanced conceptuses secrete retinol binding protein (RBP) necessary 
for their development (Rothschild et al. 2000).  However, less advanced conceptuses are 
vulnerable to rising levels of retinol and derivatives that may lead to embryonic toxicity.  As a 
result, RBP4 has been identified as a candidate gene for litter size based on its transport and 
buffering ability (Rothschild et al. 2000).  Previous research of RBP in cattle and sheep suggest 
RBP to be regulated by endocrine cues of P4 and estradiol (Harney et al. 1993).   
 Collectively, these results illustrate potential molecules involved in blastocyst growth 
and conceptus elongation.  ANGPTL3, CHGA, CXCL14, EFNA1, EFNB1, and RBP4 were 
regulated by P4 via the decline and loss of PGR from uterine LE and GE.  LGALS3 was induced 
by P4 and stimulated by IFNT, similar to ruminant specific family member LGALS15.  FABP3, 
IFNG and IL6 are indicated to be regulated by IFNT from the conceptus due to up-regulation of 
mRNA levels in Day 12 P4-treated endometrium.  Further observations of these candidate genes 
during early pregnancy need to be assessed to generate expression profiles.  CXCL14 and IL6 
expressed the greatest mRNA levels in the present study of candidate genes analyzed.  In situ 
hybridization reported CXCL14 to be present within LE and GE (Satterfield et al. 2009).  
CXCL14 mRNA expression in LE and GE along with observations made in mice (Kuang et al. 
2009a), denotes CXCL14 as a regulator of trophectoderm growth in sheep.  Thus, this study has 
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identified a number of candidate endometrial genes whose products are proposed regulators of 
blastocyst growth and conceptus elongation, and mediate effects of ovarian P4 and/or the 
conceptus on endometrial function during early pregnancy. 
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CHAPTER IV 
EFFECTS OF THE ESTROUS CYCLE AND EARLY PREGNANCY ON GENE 
EXPRESSION IN THE ENDOMETRIUM OF THE OVINE UTERUS 
 
Introduction 
 During peri-implantation, maternal environment and conceptus (embryo and associated 
extraembryonic membranes) interactions are important to the success in establishing and 
maintaining pregnancy.  The maternal environment is influenced by continuous P4 exposure to 
synthesize and secrete a variety of substances, collectively termed histotroph.  Histotroph is a 
complexity of adhesion proteins, cytokines, enzymes, hormones, growth factors, protease 
inhibitors, serum proteins, transport proteins, and other substances (Spencer et al. 2004b; Bazer 
et al. 2009).  Endometrial glands and their secretions are required for elongation as evidenced by 
the uterine gland knock out (UGKO) ewe (Gray et al. 2000b; Gray et al. 2001b). 
 In sheep, the preimplantation embryo enters the uterus on Days 4 to 5 post-mating at the 
morula stage.  The morula develops into a blastocyst which contains an inner cell mass and 
blastocoele surrounded by a monolayer of trophectoderm by Day 6 with shedding of the zona 
pellucida occurring between Days 8 and 9  (Guillomot 1995).  By Day 10, the blastocyst 
measures 0.4-0.9 mm in diameter with approximately 3000 cells (Wintenberger-Torres and 
Flechon 1974).  The hatched blastocyst will begin to elongate on Day 11, transitioning from 
spherical to tubular to filamentous morphology (Spencer et al. 2004a).  On Day 14, the 
conceptus has elongated to approximately 10 cm in length and is filamentous in form.  
Elongation is concomitant with the onset of trophectoderm giant BNC differentiation (Wooding 
1992).  Binucleate cells form syncytial plaques with uterine LE in the caruncular regions to aid 
in the formation of the cotyledonary portion of the placentome.  Additionally, binucleate cells 
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synthesize and secrete hormones, specifically chorionic somatomammotropin hormone 1 (CSH1 
or placental lactogen) and P4 (Spencer et al. 2004a).   
During elongation, the ruminant conceptus produces and secretes the maternal 
recognition of pregnancy signal, IFNT from the mononuclear trophectoderm (Bazer et al. 1979; 
Spencer et al. 2008).  IFNT inhibits the luteolytic response to prostaglandin F2α from the uterine 
epithelia by preventing up-regulation of ESR1, thereby maintaining a functional corpus luteum 
(CL) and its production of progesterone (P4) required for pregnancy (Bazer et al. 1996).  IFNT 
must be secreted by the elongating conceptus between Days 12 and 16 to be signaled to the 
maternal environment for a successful pregnancy outcome (Spencer and Bazer 2004a).  The 
trophectoderm increases 90-fold from Day 13 to 19 resulting in the elongation of the conceptus 
into the contralateral uterine horn of ovulation (Wales and Cuneo 1989).  Adhesion of the 
trophectoderm with the uterine LE begins on Day 16 and is completed around Day 22 (Boshier 
1969; Spencer et al. 2004a). 
Endometrial functions and epithelial secretions are largely regulated by P4, IFNT and 
prostaglandins (PG) during peri-implantation.  Progesterone induces expression of genes while 
IFNT and PGs regulate their activity.  Interferon stimulated genes (ISG) are expressed in a cell-
specific manner within the endometrium to promote uterine receptivity (Bazer et al. 2009).  
Progesterone induces expression of prostaglandin G/H synthase and cyclooxygenase 2 (PTG2S) 
enzymes which converts arachidonic acid to PG between Days 10 and 12.  PTGS2-derived PGs 
mediate, in part, the effects of P4 and IFNT on endometrial epithelial genes thought to be critical 
regulators of conceptus elongation (Dorniak et al. 2011).  
Satterfield et al. (2006) reported a model of accelerated blastocyst development elicited 
by advancing the postovulatory rise in circulating levels of P4 following estrus.  Their results 
indicated marked effects of early P4 supplementation on peri-implantation growth and 
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development of blastocysts by the presence of advanced stage blastocysts and filamentous 
conceptuses in uterine flushes from Days 9 and 12 of pregnancy, respectively.  Analyzing the 
transcriptome of the early supplemented P4 endometrium by microarray, Satterfield et al. (2009) 
identified novel candidate genes and regulatory pathways of peri-implantation blastocyst growth 
and conceptus development governed by P4 regulation.  Microarray and qPCR data of the early 
P4 treatment study demonstrated a number of genes to be up-regulated on Day 12, indicating 
induction of these genes to be associated with loss of PGR in uterine LE and GE.  Therefore, the 
objective of this study was to analyze candidate genes by qPCR in cyclic and pregnant ovine 
endometrium to elucidate their expression in a broader scope during the estrous cycle and early 
pregnancy. 
 
Materials and Methods 
Animals 
Mature crossbred Suffolk ewes (Ovis aries) were observed daily for estrus in the 
presence of intact vasectomized rams and were used in experiments only after having exhibiting 
two normal duration estrous cycles (16-18 Days).  All experimental and surgical procedures 
were in compliance with the Guide for the Care and Use of Agriculture Animals in Research and 
Teaching and approved by the Institutional Animal Care and Use Committee of Texas A&M 
University. 
Experimental Design 
At estrus (Day 0), the ewes were mated to either an intact or vasectomized ram and then 
hysterectomized on either Day 10, 12, 14 or 16 of the estrous cycle or Day 10, 12, 14, 16, 18 or 
20 of pregnancy (n=4-5 ewes per day and status) as described previously (Spencer et al. 1999).  
At hysterectomy, the uterus was flushed with 20 ml sterile saline.  Pregnancy was confirmed on 
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Days 10-16 post-mating by the presence of a morphologically normal conceptus(es) in the 
uterine flushing.  It was not possible to obtain uterine flushings from Day 18 and 20 pregnant 
uteri because the conceptus(es) had adhered to the uterine LE.   
At hysterectomy, sections (~0.5 cm) from the midportion of each uterine horn ipsilateral 
to the CL were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2).  After 24 h, fixed tissues 
were changed to 70% ethanol (v/v) for 24 h, dehydrated through a graded series of alcohol to 
xylene, and then embedded in Paraplast-Plus (Oxford Labware, St. Louis, MO).  The remaining 
endometrium of the ipsilateral uterine horn was physically dissected from the myometrium, 
frozen in liquid nitrogen, and stored at -80⁰C for subsequent RNA extraction.  No tissues from 
the contralateral uterine horn in monovulatory pregnant ewes were used for analysis. 
RNA Isolation and Quantitative Real-Time PCR Analysis 
Total cellular RNA was isolated from frozen ipsilateral endometrium using Trizol 
reagent (Gibco-BRL, Bethesda, MD) according to manufacturer’s instructions.  The quantity and 
quality of total RNA were determined by spectrometry and by denaturing agarose gel 
electrophoresis, respectively.  Total RNA samples were digested with RNase-free DNase I and 
were cleaned up using the RNeasy MinElute Cleanup Kit (Qiagen, Valencia, CA). 
Total RNA from each sample was reverse transcribed in a total reaction volume of 20 µl.  
Briefly, 5 µl RNA was combined with primer mix containing oligo (dT) primer (0.2 µg/µl), 
random hexamer primer (3 µg/µl) (Invitrogen, Carlsbad, CA) and incubated at 70⁰C for 10 
minutes.  A reverse transcriptase (RT) mix containing 5X first-stand buffer, RNasin, 100 mM 
dNTP, 100 mM DTT and SuperScript II RTase (Invitrogen, Carlsbad, CA) was added to the 
reaction and reverse transcription performed under following conditions: 42⁰C for 90 min and 
95⁰C for 2 min.  Complementary DNA (cDNA) preps were cleaned by phenol-choloroform 
extraction and acid-ethanol precipitation, resuspended in 20 µl of water and stored at -20⁰C.  
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Control reactions in the absence of reverse transcriptase were prepared for each sample to detect 
genomic DNA contamination.  
Quantitative PCR was performed using the ABI prism 7900HT system (Applied 
Biosystems, Foster, CA) with Power SYBR Green PCR Master Mix (Applied Biosystems, 
Foster, CA) as specified by manufacturer.  Specific oligonucleotide primers were designed and 
analyzed by Oligo 5 (Molecular Biology Insights, Inc).  Forward and reverse primer sequences 
for all genes analyzed are listed in Table 3.1.  Primer specificity and efficiency (-3.2077 > 
threshold curve > -3.447) were confirmed using a test amplification run.  Each individual sample 
was run in triplicate using the following conditions: 50⁰C for 2 min, 95⁰C for 10 min; and then 
95⁰C for 15 sec and 60⁰C for 1 min for 40 cycles.  A dissociation curve was generated to 
determine amplification of a single product.  The threshold line was set at the linear region of the 
plots above the baseline noise, and threshold cycle (CT) values were determined at the cycle 
number at which the threshold line crossed the amplification curve.  The results are expressed in 
terms of change in CT values (CT).  To adjust for variations in the amount of cDNA, the mean 
CT values for each gene were normalized against average CT values for the reference gene (ovine 
alpha-tubulin, TUBA) as follows: CT = mean CT specific gene – mean CT TUBA.  Subtraction of an 
arbitrary constant from CT, generates CT.  Finally, the relative quantification (RQ) of each 
gene was calculated as 2
-C
T.   
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In Situ Hybridization Analysis 
 Location of FABP3 and IL6 mRNAs in the ovine uterus were determined by radioactive 
in situ hybridization analysis using methods as previously described (Johnson et al. 1999b).  
Radiolabeled antisense and sense cDNA probes were generated by in vitro transcription using 
linearized partial plasmid cDNA templates, RNA polymerases, and [α-35S]-UTP.  
Deparaffinized, rehydrated, and deproteinated uterine tissue sections were hybridized with 
radiolabeled antisense or sense cRNA probes.  After hybridization, washing and ribonuclease A 
digestion, slides were dipped in NTB-2 liquid photographic emulsion (Kodak, Rochester, NY), 
and exposed at 4⁰C for 1 week for FABP3 and 3 weeks for IL6.  After development and 
counterstaining, images of the representative fields were recorded under bright- and dark-field 
illumination.   
Statistical Analysis 
  Relative quantification values were subjected to least-squares analysis of variance using 
the General Linear Models procedures of the Statistical Analysis System (SAS Institute, Cary, 
NC).  Data from ewes on Days 10, 12, 14 and 16 were analyzed for the effects of day, status 
(cyclic or pregnant) and their interactions.  A P value of 0.05 or less was considered significant.  
Data are presented as the least-squares means with overall standard errors. 
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Results 
 
 
Figure 4.1.  mRNA levels of candidate genes in endometrium from cyclic and pregnant ewes as 
determined by qPCR.  Relative quantification of A) ANGPTL3, B) CHGA, C) CXCL14, D) 
EFNA1, E) EFNB1, F) FABP3, G) IFNG, H) IL6, I) LGALS3, J) PTH, K) RBP4, L) SLIT2, M) 
SLIT3, and N) VWF.  Data presented as least-square mean RQ with standard error (SE). 
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Figure 4.1 continued.   
 
 
The present study analyzed microarray identified candidate genes in cyclic and pregnant 
endometrium.  Genes affected by day, status and/or their interaction over Days 10 to 16, or 
highly up-regulated over Days 18 and 20 of pregnancy are presented in Figure 4.1.  CLEC4E 
was not affected by day or status (cyclic or pregnant), thereby results are not presented. 
Overall, ANGPTL3 mRNA was greater (status, P < 0.01) in pregnant endometrium 
compared to cyclic during Days 10 to 16.  mRNA increased (P < 0.001) 2.6-fold from Day 10 to 
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12 (day, P < 0.01).  ANGPTL3 mRNA in pregnant endometrium was 2.2-fold greater (P < 0.01) 
than cyclic endometrium mRNA levels on Day 12.  Greatest ANGPTL3 mRNA was observed in 
Day 12 pregnant endometrium.  mRNA levels decreased (P < 0.001) 4.5-fold from Days 12 to 
20 of pregnancy.  
 CHGA mRNA levels were greater in pregnant endometrium across Days 10 to 16 
(status, P < 0.01).  CHGA levels across days were similar for status until Day 16, which pregnant 
mRNA was 54-fold higher (P < 0.05) than cyclic endometrium.  CHGA mRNA increased 1.8-
fold from Day 10 to highest expression observed on Day 12.  CHGA levels then decreased (P < 
0.001) 60-fold from Day 12 to Day 20 of pregnancy.   
 CXCL14 mRNA levels were greater overall in pregnant endometrium from Days 10 to 
16 (status, P < 0.01; day x status, P < 0.01).  mRNA levels increased (P < 0.001) 56.7-fold from 
Day 10 to Day 14 of pregnancy.  CXCL14 expression decreased (P < 0.001) 2.6-fold after Day 
14 in pregnant endometrium to cyclic levels on Day 16 (day, P < 0.01). 
 EFNA1 was greater in pregnant endometrium across Days 10 to 16 (status, P < 0.0001; 
day x status, P < 0.01).  EFNA1 mRNA increased (P < 0.001) 2.5-fold from Day 10 to 12 of 
pregnancy.  EFNA1 was highest in Day 12 endometrium for both cyclic and pregnant 
endometrium (day, P < 0.001).  Pregnant endometrium EFNA1 mRNA decreased (P < 0.001) 2-
fold from Day 12 to Day 20 of pregnancy. 
 EFNB1 mRNA expression is similar to family member, EFNA1 with greatest mRNA 
levels in pregnant endometrium (status, P < 0.001; day x status, P < 0.05).  mRNA levels 
increased (P < 0.001) 2-fold from Day 10 to 12 in pregnant endometrium.  Greatest expression 
was observed in Day 12 endometrium for both pregnant and cyclic endometrium (day, P < 0.01).  
EFNB1 mRNA decreased (P < 0.001) 2.5-fold from Days 12 to 20 of pregnancy. 
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 LGALS3 mRNA was greater overall in pregnant endometrium from Days 10 to 16 
(status, P < 0.001).  LGALS3 increased (P < 0.001) 2.5-fold from Day 10 to 12 of pregnancy 
(day, P < 0.001).  Cyclic mRNA levels decreased (P < 0.001) 3-fold from Day 12 to Day 16 of 
the estrous cycle whereas LGALS3 mRNA remained high to Day 16 of pregnancy (day x status, 
P < 0.01).  LGALS3 decreased (P < 0.05) 1.5-fold from Day 16 to 20 of pregnancy.   
 RBP4 mRNA levels were greater overall in pregnant endometrium from Days 10 to 16 
(status, P < 0.001; day x status, P < 0.05).  RBP4 increased (P < 0.001) 3.3-fold from Day 10 to 
Day 12 of pregnancy (day, P < 0.001).  RBP4 remained abundant throughout Days 12 to 16.  
RBP4 mRNA then decreased (P < 0.001) 2.3-fold from Days 16 to 20 of pregnancy.  RBP4 
mRNA decreased (P < 0.001) 3.2-fold from Day 12 to 16 of the estrous cycle.   
 SLIT2 mRNA levels were not affected by status (P >0.10) during Days 10 to 16, 
however expression was differentiated over days (day, P < 0.01) with highest expression on Day 
12 in both cyclic and pregnant endometrium.  SLIT3 mRNA levels were similar to SLIT2, with 
highest mRNA levels observed on Day 12 (day, P < 0.001) in both cyclic and pregnant 
endometrium. 
 VWF mRNA levels were greater overall in pregnant endometrium from Days 10 to 16 
(status, P < 0.01; day x status, P < 0.01).  VWF mRNA levels were similar Days 10 to 16 in 
pregnant endometrium, then decreased (P < 0.01) 2.6-fold from Day 16 to 20 of pregnancy.  
VWF mRNA levels decreased (P < 0.001) 12.9-fold from Day 12 to 16 of the estrous cycle. 
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PTH mRNA levels were greater overall in cyclic endometrium (status, P < 0.001).  PTH 
mRNA levels remained low in pregnant endometrium whereas in cyclic endometrium, mRNA 
increased (P < 0.001) 3-fold from Days 10 to 16 of the estrous cycle. 
FABP3 was indicated to be regulated by IFNT from the early P4 study in addition with 
IFNG and IL6.  FABP3 was not affected by day or status during Days 10 to 16.  FABP3 was up-
regulated 21-fold from Day 14 to 18 of pregnancy.  In situ hybridization analysis presented in 
Figure 4.2 identified FABP3 mRNA in LE, sGE and trophectoderm on Days 18 and 20 of 
pregnancy (Figure 4.2). 
 IFNG mRNA was greater overall in pregnant endometrium from Days 10 to 16 (status, 
P < 0.01; day x status, P < 0.05).  IFNG mRNA increased 3.4-fold from Day 10 to Day 14 of 
pregnancy and remained high.  IFNG mRNA in pregnant endometrium on Day 14 was 2.2-fold 
greater (P < 0.01) that cyclic endometrium. 
 IL6 mRNA was not affected by day or status during Days 10 to 16.  However, IL6 
mRNA was up-regulated 37-fold from Days 14 to 20.  In situ hybridization analysis presented in 
Figure 4.3 identified IL6 to be localized in immune cells within the LE on Day 18 and present at 
the fetomaternal interface on Day 20 of pregnancy. 
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Figure 4.2.  In situ hybridization analysis of FABP3 mRNA in the uteri of cyclic and pregnant 
ewes.  Cross sections of the uterine wall from cyclic (C) and pregnant (P) ewes were hybridized 
with radiolabeled antisense or sense FABP3 cRNA probes.  FABP3 mRNA was present 
predominantly in the LE and sGE on Days 18 and Day 20 of pregnancy.  FABP3 mRNA was 
also present in the trophectoderm.  In pregnant ewes, FABP3 mRNA increased 21-fold between 
Days 14 to Day 18 and remained abundant on Day 20.  LE, luminal epithelium; GE, glandular 
epithelium, S, stroma; Tr, trophectoderm.  15X magnification. 
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Figure 4.3.  In situ hybridization analysis of IL6 mRNA in the uteri of cyclic and pregnant ewes.  
Cross sections of the uterine wall from cyclic (C) and pregnant (P) ewes were hybridized with 
radiolabeled antisense or sense IL6 cRNA probes.  IL6 mRNA localized to immune cells within 
the uterine LE on Day 18, and to LE and sGE on Day 20 of pregnancy.  IL6 was also present in 
the trophectoderm.  In pregnant ewes, IL6 increased 37-fold between Days 14 to Day 20.  LE, 
luminal epithelium; GE, glandular epithelium, S, stroma; Tr, trophectoderm.  15X magnification. 
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Discussion 
ANGPTL3 mRNA was up-regulated in pregnant endometrium on Day 12 to levels 
greater than cyclic endometrium.  However, ANGPTL3 expression did not remain abundant.  Up-
regulation of ANGPTL3 from Day 10 to 12 is in association with the loss of PGR.  These results 
are in agreement with the previous study conducted in early P4-treated ovine endometrium.  
Furthermore, ANGPLT3 pregnant mRNA levels were greater than cyclic endometrium levels 
suggesting regulation by conceptus factors.  Thus ANGPTL3 may be induced by P4 and 
regulated by conceptus factors.  ANGPTL3 stimulates cell adhesion and migration of human 
umbilical venous endothelial cells and human microvascular vein endothelial cells via integrin 
αvβ3 in vitro (Camenisch et al. 2002).  ANGPTL3 may be involved in migration and adhesion 
during peri-implantation in sheep. 
CHGA mRNA levels increased from Day 10 to 12, therefore indicating CHGA 
expression is stimulated by down-regulation of PGR.  CHGA expression decreased after Day 12 
in both cyclic and pregnant endometrium.  CHGA is a ubiquitous protein that is co-secreted with 
hormones, enzymes, neuropeptides and neurotransmitters to regulate secretory granule 
biosynthesis.  Stimulation of CHGA by P4 is concomitant with endometrial secretions regulated 
by P4.  CHGA expression was overall greater in pregnant endometrium however pregnant 
mRNA levels were only significant on Day 16.  CHGA may serve to regulate secretion of a co-
resident product in histotroph.   
CXCL14 mRNA increased 56.7-fold from Days 10 to 14 of pregnancy.  In situ analysis 
of CXCL14 mRNA in Days 10 to 20 pregnant endometrium showed expression in LE and GE, as 
observed in the early P4 samples reported by Satterfield et al. (2009).  CXCL14 mRNA was also 
expressed in deep GE (unpublished observations).  CXCL14 inhibited trophoblast invasion by 
down regulating MMP2 and MMP9 in mice and humans, and may balance other invasive 
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promoting chemokines during implantation (Kuang et al. 2009a).  Chemokines affect blastocyst 
development, migration and attachment (Hannan et al. 2006; Salamonsen et al. 2007).  CXCL14 
may be involved in regulating depth of papillae, trophectoderm structures which protrude into 
glands to increase surface area for histotroph absorption according to observations of CXCL14 
expression in GE and deep GE.  Increased CXCL14 mRNA on Day 14 may serve as a temporal 
regulator of trophoblast elongation and to maintain synchrony between the conceptus and 
maternal environment.   
EFNA1 and EFNB1 mRNA levels were similar in expression profiles.  mRNA levels 
increased from Day 10 to 12, indicating gene regulation by P4.  Furthermore, pregnant 
endometrium mRNA levels were higher across Days 12 to 16, suggesting regulation by 
conceptus factors.  EFNA1 is expressed in human LE and is proposed to promote the 
intracellular dissociation of the LE during implantation in humans (Fujii et al. 2011).  EFNB1 
modulates integrin-mediated cell attachment and migration during angiogenesis via αvβ3 and αvβ5 
subunits (Huynh-Do et al. 2002) which are also expressed on the apical surface of uterine LE 
and trophectoderm in sheep (Johnson et al. 2001a).  These molecules may have implications in 
uterine receptivity by modulating cell attachments and migration, specifically EFNA1 and 
EFNB1 may serve roles in the migration of BNC during syncytial formation.  Placentation in 
sheep is not invasive in comparison to rodent and humans, however trophectoderm cells are 
thought to fuse with uterine LE to form multinucleated cells in formation of the 
synepitheliochorial placenta (Wooding 1984; Spencer et al. 2004a).   
LGALS3 was higher in pregnant endometrium beginning Day 12 and throughout early 
pregnancy indicating LGALS3 to be induced by P4 and regulated by IFNT, similar to family 
member LGALS15 (Satterfield et al. 2006).  In humans, LGALS3 is expressed in epithelia, 
decidualized stroma and trophoblast during early pregnancy (von Wolff et al. 2005).  In sheep, 
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LGALS3 was expressed in mid-gestation placenta but decreased in term placenta (Iglesias et al. 
1998).  LGALS3 purified from mid-gestation placentae were discovered to increase lymphocyte 
proliferation response in vitro.  Survival of double null Lgals3 and closely related, Lgals1 mice 
suggests these molecules are optimizing agents (Poirier 2002).  LGALS3 functions in cell 
growth (Barondes et al. 1994), differentiation and angiogenesis of endothelial cells (Nangia-
Makker et al. 2000),  mediation of inflammation and leukocyte adhesion (Almkvist and Karlsson 
2004), and chemoattract for monocytes and macrophages  (Sano et al. 2000).  These functions 
taken with LGALS3 expression at the fetomaternal interface during early pregnancy in women, 
delineate LGALS3 to play a role during implantation.  Furthermore, LGALS3 modulates cell 
adhesion by binding to several ligands including laminin, fibronectin and integrins after its 
secretion from epithelial cells (Andre et al. 1999; Hughes 1999).  Up-regulation of LGALS3 
mRNA on Day 12 is in coordination with PGR down regulation and the onset of elongation in 
sheep.  Thus LGALS3 may be an optimizing molecule involved in trophectoderm elongation.   
RBP4 mRNA was up-regulated in pregnant endometrium on Day 12, remained abundant 
to Day 16 and decreased on Days 18 and 20.  RBP4 expression was greater in pregnant 
endometrium therefore indicating RBP4 is induced by P4 and regulated by conceptus factors.  
RBP4 is an intracellular transporter for retinol and derivatives (Kanai et al. 1968).  Retinoids 
control cell growth, differentiation and death (Gomez et al. 2006).   The ovine conceptus secretes 
RBP as early as Day 13 (Liu et al. 1992).  RBP4 expression in the endometrium during early 
pregnancy may be a protective feature.  Conceptuses are vulnerable to rising levels of retinol and 
derivatives that may lead to embryonic toxicity of these compounds (Rothschild et al. 2000).  
The conceptus may not be able to produce adequate amount of RBP4 alone and the endometrium 
may expresses RBP4 as a protective measure during the time frame of embryogenesis, in which 
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retinoic acid serves as a morphogen, thereby ensuring homeostatic levels of retinoids in the 
conceptus environment (Liu et al. 1992). 
SLITs are chemorepellent molecules involved in axon guiding, cell migration and 
promoter of cell death (Dickinson and Duncan 2010).  SLIT2 and SLIT3 were shown to be down-
regulated in the deciduas of early pregnancy in women, with SLIT2 expressed in LE and GE, and 
to a lesser extent in underlying stroma (Duncan et al. 2010).  Both SLIT2 and SLIT3 mRNA was 
at the greatest level during the mid-secretory in women.  In sheep endometrium, SLIT2 and 
SLIT3 had similar mRNA levels across cyclic and pregnant tissues with the exception of Day 12, 
which pregnant endometrium mRNA levels were greater.  Observation of SLIT2 in LE and sGE 
in human endometrium implicates these molecules to be involved in conceptus interactions.  
Additionally, increased cortisol as a result of HSD11B1 expression is associated with reduced 
SLIT/ROBO expression in the ovary (Dickinson and Duncan 2010).  SLIT2 and SLIT3 may be 
up-regulated by P4 but down-regulated by cortisol due to increased activity of HSD11B1.  
Down-regulation of SLIT expression would be optimal to promote cell migration and 
angiogenesis that is inhibited by SLIT expression (Guan et al. 2003). 
VWF mRNA levels were similar between cyclic and pregnant endometrium on Day 12, 
although cyclic VWF mRNA decreased while pregnant VWF mRNA remained high to Day 18.  
VWF is uniquely expressed in endothelial cells and by megakaryocytes to mediate platelet 
adhesion at sites of vascular injury (McGrath et al. 2010).  VWF is commonly used as an 
endothelial marker and detecting angiogenesis during tumor growth (Zanetta et al. 2000).  
Angiogenesis occurs in fetal and maternal placental tissues to develop a hematotrophic delivery 
system to supply the fetus with metabolic substrates via transplacental exchange (Grazul-Bilska 
et al. 2011).  Angiogenic molecules are up-regulated after Day 20 (Grazul-Bilska et al. 2011), 
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beyond the scope of the present study.  Thus VWF would not likely be differentiated expressed 
until later in pregnancy. 
In contrast to the previous genes, PTH mRNA was greater in cyclic endometrium than 
pregnant endometrium.  PTH plays a role in fetal calcium homeostasis (Simmonds et al. 2010) 
however no information of PTH during early pregnancy is known.  With these results, and 
observations of no significant changes in the early P4 study suggests PTH does not play a major 
role during early pregnancy in sheep. 
FABP3 mRNA levels increased 21-fold from Day 14 to Day 18 of pregnancy.  From 
analysis in early P4-treated endometrium, FABP3 was suggested to be regulated by IFNT.  
However FABP3 up-regulation in pregnant endometrium during this study was concomitant with 
binucleate cell differentiation (Spencer et al. 2004a).  Interestingly, FABP3 expression is up-
regulated in differentiated tissues (Borchers et al. 1997; Tang et al. 2004) and human term 
syncytiotrophoblasts (Daoud et al. 2005).  Additionally, syncytiotrophoblasts had a greater 
efflux of linoleic acid transport associated with increased FABP3 expression.  Interestingly, 
FABP3 mRNA was localized to the fetomaternal interface Days 18 and 20 of pregnancy in 
sheep, concomitant with implantation.  FABP3 may serve to translocate fatty acids to the 
conceptus during implantation for cellular membrane development and precursor molecules for 
prostaglandin signaling. 
Up-regulation of FABP3 by conceptus factors, likely increases intracellular fatty acid 
trafficking thus making fatty acids readily available.  Fatty acids during early pregnancy are 
important for synthesis of eicosanoids (PGs, tromboxanes and leukotrienes) (Mattos et al. 2000),  
maintaining cellular and organelle integrity (Duttaroy 2009), and mediating gene expression 
(Sampath and Ntambi 2005). 
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IFNG mRNA was up-regulated by Day 14 in pregnant endometrium at levels higher 
than cyclic endometrium.  The increase of IFNG mRNA levels on Day 14 is concomitant with 
conceptus factors, such as IFNT.  However, IFNG is not reported to be secreted by the ruminant 
trophectoderm as reported to occur by pig conceptuses (Bazer et al. 2008).  Activation of IFNG 
production in innate immune cells is typically preceded by signaling from type 1 IFN (Murphy et 
al. 2009). In pigs, IFNG affects blastocyst attachment to LE by remodeling uterine epithelia to 
affect polarity, and stimulate PGE2 production (Bazer et al. 2008).   
IL6 mRNA levels increased 37-fold from Days 14 to 20 of pregnancy.  In situ analysis 
identified IL6 mRNA in immune cells within uterine LE and sGE on Day 18 and 20 of 
pregnancy.  Additionally, IL6 mRNA was observed in trophectoderm.  IL6 regulates various 
aspects of the immune response, acute phase reaction and hematopoiesis, and has functional 
redundancy with IL-11 and LIF (Dimitriadis et al. 2005).  LIF has been implicated in the growth 
and differentiation of trophectoderm into giant BNC in sheep (Song et al. 2009).  In vitro culture 
demonstrates IL6 to stimulate cell migration, invasion and integrin expression in human 
extravillous trophoblast cells.  IL6 up-regulated α1, α5, β1 proteins, thereby increasing cell 
migration (Jovanovic and Vicovac 2009).   Placentas from preeclamptic pregnancies were found 
to produce less IL6 under normoxia compared to normal placenta, indicating endogenous IL6 is 
important for trophoblast invasion (Zhao et al. 2008).   IL6 may serve to promote trophoblast 
migration in sheep as well as invasion of the uterine LE such as closely related molecule, LIF 
which is implicated in differentiation of the trophectoderm into giant BNC. 
Collectively, the results from candidate genes identified by microarray in early P4-
treated endometrium analyzed in cyclic and pregnant endometrium provide information on 
potential regulators governing blastocyst growth and conceptus elongation during peri-
implantation.  Potential migration and adhesion molecules include ANGPTL3, EFNA1, EFNB1 
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and LGALS3, of which appear to be P4-induced and regulated by conceptus factors.  Angiogenic 
factors identified included SLIT2, SLIT3 and VWF, however their expression was down-
regulated during later days analyzed.  CHGA and RBP4 were up-regulated on Day 12 in concert 
with down-regulation of PGR, may have implications in granule secretion and transport of 
protein, respectively.  CXCL14, indicated to regulate trophoblast outgrowth in sheep conceptus 
was up-regulated 7-fold on Day 14 of pregnancy in comparison to cyclic endometrium.  Another 
cytokine, IL6 increased 37-fold from Days 14 to 20 of pregnancy.  In situ hybridization analysis 
demonstrated IL6 mRNA to be localized to immune cells on Day 18 of pregnancy and at the 
fetomaternal interface on Day 20 of pregnancy.  IL6 may be involved in implantation and 
differentiation of the trophectoderm into BNC.  FABP3 mRNA was increased 21-fold from Days 
14 to 18 of pregnancy and localized to uterine LE and sGE as well as trophectoderm.  FABP3 
may serve as an intracellular transporter of fatty acids at the fetomaternal interface during 
conceptus development. 
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CHAPTER V 
SUMMARY 
 
In summary, the studies conducted analyzed genes identified by microarray that were 
proposed to govern peri-implantation blastocyst growth and conceptus development.  These 
genes included ANGPTL3, CHGA, CLEC4E, CXCL14, EFNA1, EFNB1, FABP3, IFNG, IL6, 
LGALS3, PTH, RBP4, SLIT2, SLIT3 and VWF.  Analysis of these genes by qPCR was conducted 
in two studies.  The first study indicates ANGPTL3, CHGA, CXCL14, EFNA1, EFNB1, LGALS3 
and RBP4 to be regulated by P4 via loss of PGR based on observation of up-regulation of these 
genes in early P4-treated endometrium.  FABP3, IFNG and IL6 were up-regulated in Day 12 
early P4-treated endometrium which contained elongated and filamentous conceptuses secreting 
IFNT, thus these genes are suggested to be regulated by conceptus factors such as IFNT and 
PTGS2-derived PGs.   
The second study evaluated candidate genes in cyclic and pregnant endometrium.  The 
following hypotheses are proposed of the candidate genes based on results of the second study.  
ANGPTL3 is induced by P4, regulated by conceptus factors and involved in trophectoderm 
migration and adhesion.  CHGA is induced by P4, regulated by conceptus factors and involved in 
granule secretion.  CXCL14 is induced by P4, regulated by conceptus factors to mediate 
trophectoderm growth.  EFNA1 and ENFB1 are induced by P4, regulated by conceptus factors 
and involved in adhesion between the trophectoderm and uterine LE.  FABP3 is regulated by 
conceptus factors related to BNC differentiation and involved in intracellular transport of fatty 
acids at the fetomaternal interface.  IFNG is regulated by IFNT and implicated in immune 
function at the fetomaternal interface.  IL6 is regulated by conceptus factors and involved in 
implantation by migration and differentiation of trophectoderm.  LGALS3 is induced by P4, 
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regulated by IFNT and implicated as an adhesion molecule.  RBP4 is induced by P4, regulated 
by conceptus factors and affects availability of retinoids to the conceptus.   
Future studies should be directed at testing hypotheses of genes regulated by conceptus 
factors, including IFNT and PTGS2-derived PG mediation of gene expression.  Protein 
localization for CXCL14, FABP3 and IL6 should be conducted to complement in situ 
hybridization results and confirm spatial and temporal expression.  In vitro studies of CXCL14, 
FABP3 and IL6 are warranted to elucidate roles of trophectoderm growth and nutrient transport 
function during early pregnancy in ovine. 
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